Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3052649	s-ada	U/l (u/l)	2950	4084	1.35%
3052649	s-ada	— (—)	209	241	100.00%	Distribution not available
3052649	s-ada	U/l_______ (u/l)	41	58	0.00%
3052649	s-ada	__________ (—)	16	18	100.00%	Distribution not available
3052649	s-ada	U/L (u/l)	5	5	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Asthma

499

227

11.43

320.73

1.5

1.3

12.09

12.96

u/l

0.96

483

221

Asthma (only as main-diagnosis)

465

227

11.55

317.26

1.5

1.3

12.42

12.96

u/l

0.48

453

221

Heart failure, not strict

850

1248

4.65

309.83

1.5

1.4

14.15

11.73

u/l

10.92

814

1217

ILD differential diagnosis

567

230

12.47

307.65

1.5

1.3

12.23

13.06

u/l

0.90

549

224

Suppurative and necrotic conditions of lower respiratory tract

295

169

19.85

307.65

1.6

1.4

11.55

13.99

u/l

3.51

286

160

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

905

1864

4.30

307.65

1.5

1.4

12.88

13.18

u/l

0.54

873

1801

Pneumonia, organism unspecified

1115

1386

5.60

307.65

1.4

12.66

12.64

u/l

0.03

1074

1351

Other medical care

745

1258

5.08

307.65

1.5

1.4

12.92

12.85

u/l

0.06

725

1218

Other pulmonary diagnosis

580

228

12.87

307.65

1.5

1.3

12.24

12.96

u/l

0.78

562

222

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1162

1473

5.33

307.65

1.5

1.4

12.73

12.65

u/l

0.10

1119

1436

Malignant neoplasm of respiratory system and intrathoracic organs

538

516

9.05

307.65

1.4

11.18

13.70

u/l

10.93

521

493

Excluding asthma or asthma-COPD overlap

570

228

12.65

307.65

1.5

1.3

12.31

12.96

u/l

0.68

552

222

Influenza and pneumonia

1155

1413

5.11

307.65

1.5

1.4

12.62

12.60

u/l

0.02

1115

1377

1036

1117

5.50

307.65

1.5

1.4

12.62

12.60

u/l

0.01

1001

1088

COPD differential diagnosis

568

230

12.49

307.65

1.5

1.3

12.25

13.06

u/l

0.88

550

224

Pneumonias (Asthma/COPD co-morbidities)

1166

1457

5.30

307.65

1.5

1.4

12.70

12.64

u/l

0.09

1124

1420

Other diseases of pleura

1931

610

29.82

307.65

1.5

1.3

12.81

14.07

u/l

2.46

1875

580

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

598

559

9.20

307.65

1.4

11.27

13.72

u/l

11.45

578

535

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1036

1117

5.50

307.65

1.5

1.4

12.62

12.60

u/l

0.01

1001

1088

Pyothorax

263

135

22.73

307.65

1.6

1.4

11.55

13.70

u/l

3.07

255

128

All pneumoniae

1162

1455

5.26

307.65

1.5

1.4

12.70

12.64

u/l

0.07

1120

1418

Abnormal findings on diagnostic imaging of lung

772

1578

4.74

307.65

1.4

12.87

13.43

u/l

1.13

744

1523

Pleural effusion

1534

203

95.63

307.65

1.5

1.3

12.79

14.04

u/l

1.23

1500

191

Other pleural conditions

771

125

73.87

307.65

1.5

1.4

12.86

14.19

u/l

1.04

745

118

Heart failure,strict

729

1012

5.13

299.99

1.5

1.3

14.29

11.87

u/l

12.39

696

983

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1045

1882

3.79

295.83

1.6

1.3

13.92

12.28

u/l

6.49

1012

1819

Bacterial infection, other or unspecified, including avohilmo

789

1473

4.47

294.90

1.5

1.4

14.03

12.45

u/l

4.26

750

1428

Bacterial infection, other or unspecified

754

1411

4.59

294.35

1.5

1.4

14.05

12.61

u/l

3.50

717

1368

Malignant neoplasm of bronchus and lung, including Hilmo

455

518

7.60

290.78

1.3

1.4

11.45

13.71

u/l

8.52

440

495

Asthma (mode)

459

230

10.56

286.71

1.5

1.3

12.07

13.06

u/l

1.09

447

224

Any death

777

1225

4.52

277.77

1.4

13.31

12.59

u/l

1.22

743

1194

Other bacterial diseases

982

1742

3.78

275.41

1.5

1.4

13.86

12.26

u/l

6.01

949

1692

Heart failure, strict

799

1359

4.16

257.79

1.5

1.4

14.31

12.53

u/l

7.26

764

1315

Early onset COPD, excluding more controls

192

20.77

253.59

1.5

1.3

11.58

13.63

u/l

1.61

187

All-cause Heart Failure

775

1337

4.11

245.90

1.5

1.4

14.29

12.51

u/l

7.08

740

1294

Malignant neoplasm of bronchus and lung

397

472

7.29

245.40

1.3

1.4

11.36

13.74

u/l

8.87

385

450

Dyspnoea

943

1970

3.49

243.97

1.5

1.4

12.99

12.86

u/l

0.18

913

1903

Fever of other and unknown origin

670

1378

4.27

242.07

1.5

1.4

13.56

12.44

u/l

2.83

645

1336

Other bacterial diseases, including avohilmo

952

1685

3.56

241.36

1.5

1.4

13.72

12.13

u/l

5.85

922

1635

Non-small cell lung cancer, including Hilmo

333

413

7.87

230.93

1.3

1.4

11.10

13.81

u/l

10.01

320

392

Diseases of the respiratory system

399

245

8.23

208.45

1.5

1.2

12.75

13.20

u/l

0.35

384

238

First line medication for Crohn's disease

928

1572

3.20

190.88

1.5

1.4

12.71

13.05

u/l

0.55

901

1512

Non-small cell lung cancer

244

286

8.80

189.67

1.4

10.90

13.90

u/l

8.72

234

273

Oxycodone

523

1097

4.15

180.81

1.5

1.4

12.42

13.05

u/l

1.00

501

1057

Oral corticosteroids

938

1844

3.01

179.90

1.5

1.4

12.66

12.89

u/l

0.37

910

1777

Bacterial Sepsis

609

1374

3.72

179.85

1.5

1.4

14.46

12.66

u/l

5.94

580

1332

Bacterial pneumoniae

458

903

4.52

178.61

1.5

1.4

12.97

13.12

u/l

0.14

439

882

Bacterial pneumonia, not elsewhere classified

446

869

4.58

176.57

1.5

1.4

12.95

13.04

u/l

0.07

428

849

Persons encountering health services for specific procedures and health care

872

1683

3.08

174.60

1.5

1.4

13.01

12.48

u/l

0.88

838

1633

Heart failure and antihypertensive medication

327

324

6.69

168.21

1.6

1.3

14.02

11.27

u/l

6.22

310

311

Malignant neoplasm of mesothelium and soft tissue

135

19.01

168.04

1.7

1.3

10.42

14.11

u/l

4.84

130

ILD medications: prednisolone, methylprednisolone, prednisone

911

1721

2.97

167.78

1.5

1.4

12.86

12.74

u/l

0.15

883

1660

Septicaemia

522

1258

3.84

166.16

1.5

1.4

14.71

12.76

u/l

6.27

497

1218

Nonhereditary hypogammaglobulinemia

62.93

164.53

3.2

1.4

13.69

11.68

u/l

0.81

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

158

127

13.12

162.66

1.6

1.3

10.58

13.96

u/l

6.88

153

119

COPD/asthma/ILD related infections

748

1117

3.38

162.52

1.5

1.4

12.80

12.60

u/l

0.23

719

1088

COPD/asthma related infections

748

1117

3.38

162.52

1.5

1.4

12.80

12.60

u/l

0.23

719

1088

Inflammatory bowel disease treatment related agents

946

1861

2.84

161.83

1.5

1.4

12.84

12.87

u/l

0.03

917

1794

Non-small cell lung cancer, adenocarcinoma

167

149

11.88

161.06

1.3

10.50

14.53

u/l

7.05

157

141

Abnormalities of breathing

737

1298

3.27

160.60

1.4

12.75

12.65

u/l

0.10

718

1264

Explicit Sepsis, including avohilmo

545

1387

3.62

158.67

1.5

1.4

14.93

12.54

u/l

7.72

519

1346

Implicit bacterial Sepsis

541

1297

3.64

156.06

1.6

1.4

14.51

12.69

u/l

5.32

513

1257

Other septicaemia, including avohilmo

483

1198

3.85

155.20

1.5

1.4

14.62

12.63

u/l

5.72

461

1160

Renal tubulo-interstitial diseases

787

1987

2.93

154.49

1.5

1.4

14.07

12.33

u/l

7.13

754

1930

Implicit bacterial Sepsis, including avohilmo

565

1355

3.52

154.26

1.5

1.4

14.43

12.68

u/l

5.20

536

1313

ILD medications

906

1729

2.84

153.95

1.5

1.4

12.99

12.74

u/l

0.36

877

1668

Explicit Sepsis

531

1376

3.57

151.76

1.5

1.4

14.90

12.60

u/l

7.34

506

1335

Other septicaemia

468

1176

3.81

148.81

1.5

1.4

14.57

12.71

u/l

5.22

447

1138

Non-ischemic cardiomyopathy

422

804

4.25

146.57

1.5

1.3

13.85

12.36

u/l

3.59

404

776

Implicit Sepsis

701

1739

3.00

143.58

1.5

1.4

13.93

12.32

u/l

5.46

668

1690

Liquid cancers, including Hilmo

390

811

4.31

143.34

1.5

15.69

13.51

u/l

2.89

376

778

Liquid cancers

337

715

4.54

135.26

1.6

1.4

16.36

13.62

u/l

3.49

323

687

Renal failure

590

1660

3.07

130.50

1.5

1.4

15.08

12.84

u/l

8.32

557

1607

Any gastric operation

464

581

4.03

127.72

1.5

1.3

12.55

11.95

u/l

0.92

451

555

GASTRO-related operations

464

581

4.03

127.72

1.5

1.3

12.55

11.95

u/l

0.92

451

555

Anaemias

165

12.28

127.37

1.7

1.5

14.19

10.66

u/l

3.70

160

All chronic kidney diseases

576

1514

3.07

125.37

1.5

1.4

14.59

12.56

u/l

6.96

550

1469

Heart failure and bmi 25plus

404

688

3.98

121.90

1.5

1.4

14.75

13.03

u/l

3.22

384

666

All kidney diseases

770

1974

2.63

121.43

1.5

1.4

13.96

12.18

u/l

7.31

744

1918

Implicit Sepsis, including avohilmo

688

1792

2.76

121.22

1.5

1.4

13.86

12.26

u/l

5.26

657

1743

Kela reimbursement Agammaglobulinemia (D80-84)

113

342.81

118.35

3.2

1.2

13.92

11.00

u/l

—

113

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

282

605

4.60

116.07

1.4

11.21

13.51

u/l

8.41

271

582

ILD medications: immunosuppressive drugs

493

1450

3.10

113.67

1.5

1.4

14.11

12.56

u/l

3.18

475

1404

Other heart diseases, wide

600

1238

2.95

113.26

1.5

1.4

12.76

11.71

u/l

2.67

577

1205

Non-invasive ventilation

225

349

5.63

112.40

1.6

1.3

11.76

11.09

u/l

0.70

213

339

Non-small cell lung cancer, adenocarcinoma, helper endpoint

167

239

7.38

111.64

1.3

1.4

10.50

13.51

u/l

7.13

157

227

Bacterial pneumonia (organism specified)

491

1503

3.00

105.96

1.5

1.4

13.12

13.23

u/l

0.12

470

1457

Condition for Implicit Sepsis (Organ dysfunction codes)

667

1788

2.60

104.01

1.5

1.4

13.85

12.23

u/l

5.19

638

1740

Other heart diseases

300

444

4.43

103.04

1.5

1.4

12.66

10.95

u/l

2.97

286

436

Malignant neoplasm

574

1181

2.87

101.97

1.5

1.4

12.06

13.01

u/l

2.32

558

1140

Malignant neoplasm

571

1179

2.86

100.80

1.5

1.4

12.06

13.00

u/l

2.26

555

1139

COPD

504

1424

2.91

100.68

1.5

1.4

12.44

13.51

u/l

3.21

487

1372

Valvular heart disease excluding rheumatic fever

399

841

3.42

100.40

1.5

1.4

14.46

11.95

u/l

4.95

384

813

Non-rheumatic valve diseases

397

837

3.42

99.73

1.6

1.4

14.49

11.97

u/l

4.96

382

809

Secondary uncertain malignant neoplasm

179

307

5.97

99.65

1.5

1.4

14.35

13.39

u/l

0.59

168

295

Malignant neoplasm, wide definition

575

1193

2.82

99.36

1.5

1.4

12.04

12.96

u/l

2.21

557

1152

Malignant neoplasm, including Hilmo

573

1190

2.82

98.97

1.5

1.4

12.05

12.95

u/l

2.09

555

1149

Asthma-related pneumonia

411

1346

3.08

95.54

1.5

1.4

12.56

13.52

u/l

1.98

398

1294

Chronic kidney disease

409

1286

3.11

95.32

1.5

1.4

15.20

13.08

u/l

5.68

386

1244

Asthma-related pneumonia or sepsis

411

1349

3.08

95.17

1.5

1.4

12.56

13.53

u/l

2.01

398

1297

Asthma, hospital admissions 3, pneumonia

411

1349

3.08

95.17

1.5

1.4

12.56

13.53

u/l

2.01

398

1297

Other chronic obstructive pulmonary disease

482

1396

2.86

93.59

1.5

1.4

12.44

13.52

u/l

3.16

465

1344

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

650

1761

2.51

93.51

1.5

1.4

13.73

12.11

u/l

4.84

624

1714

Solid cancers

549

1163

2.78

92.85

1.5

1.4

11.82

13.02

u/l

3.73

534

1123

Solid cancers, including Hilmo

557

1185

2.76

92.26

1.5

1.4

11.77

12.99

u/l

4.05

539

1144

Acute renal failure

294

814

3.68

90.35

1.6

1.4

14.90

12.95

u/l

3.45

278

787

Heart failure and coronary heart disease

501

1274

2.79

89.10

1.5

1.4

14.74

13.01

u/l

4.96

476

1224

Erysipelas, including avohilmo

553

1582

2.61

88.33

1.5

1.4

13.78

12.31

u/l

5.11

535

1537

Certain infectious and parasitic diseases

621

1204

2.60

87.79

1.5

1.4

13.48

11.85

u/l

4.31

599

1168

Dialysis, with operation codes

189

385

5.05

87.27

1.5

1.4

14.68

12.47

u/l

3.40

180

374

Aplastic and other anaemias

493

1729

2.64

84.37

1.5

1.4

14.70

13.03

u/l

3.70

469

1672

Asthma-related infections

510

1951

2.57

84.14

1.5

1.4

12.43

13.12

u/l

1.36

495

1887

Asthma, hospital admission 2, infections

510

1951

2.57

84.14

1.5

1.4

12.43

13.12

u/l

1.36

495

1887

Nephropathy related operations

183

378

4.98

83.17

1.5

1.4

14.63

12.81

u/l

2.23

174

364

Any event in cancer register

570

1302

2.57

82.97

1.5

1.4

11.93

12.99

u/l

3.11

552

1259

General symptoms and signs

693

1461

2.39

82.81

1.5

1.4

13.20

12.39

u/l

1.46

666

1417

Other chronic obstructive pulmonary disease, including avohilmo

539

1769

2.53

82.59

1.4

12.41

13.54

u/l

3.62

517

1709

Implicit viral Sepsis, including avohilmo

314

971

3.27

80.70

1.6

1.4

14.50

12.55

u/l

3.54

301

940

Erysipelas

458

1481

2.69

80.54

1.5

1.4

13.85

12.54

u/l

4.02

442

1437

COPD, early/later onset

488

1607

2.58

78.21

1.5

1.4

12.45

13.54

u/l

3.13

471

1549

Covid-19 confirmed case

394

1420

2.81

77.45

1.4

14.54

12.73

u/l

2.92

387

1362

Atrial fibrillation and flutter

217

310

4.56

77.01

1.4

13.31

11.04

u/l

3.63

208

302

Non-Hodgkin lymphoma, all, including Hilmo

156

300

5.31

76.84

1.6

1.4

16.58

13.36

u/l

3.35

151

288

COPD, hospital admissions

481

1594

2.57

76.76

1.5

1.4

12.41

13.52

u/l

3.26

464

1536

Chronic lower respiratory diseases

814

2018

2.13

76.40

1.5

1.4

12.32

13.02

u/l

1.48

789

1951

Codes for special purposes

467

1840

2.54

75.42

1.5

1.4

14.22

12.71

u/l

2.69

460

1771

Provisional assignment of new diseases of uncertain etiology

466

1840

2.53

74.94

1.5

1.4

14.20

12.72

u/l

2.60

459

1771

All influenza

220

569

3.91

74.42

1.6

1.4

13.53

12.84

u/l

0.60

213

556

COPD, hospital admission 2, with asthma infections

387

1200

2.82

73.92

1.5

1.4

12.60

13.56

u/l

2.01

371

1154

Other anaemias

453

1670

2.57

73.79

1.5

1.4

14.54

13.06

u/l

2.90

430

1614

Cerebrovascular diseases (FINNGEN)

204

324

4.45

72.80

1.4

12.72

11.00

u/l

2.60

198

316

Other and unspecified anaemias

448

1664

2.56

72.35

1.5

1.4

14.57

13.05

u/l

3.01

425

1608

Implicit viral Sepsis

233

642

3.69

72.13

1.6

1.4

14.80

12.61

u/l

2.90

224

619

Viral Sepsis

233

642

3.69

72.13

1.6

1.4

14.80

12.61

u/l

2.90

224

619

COPD related to multimorbidity

439

1446

2.60

71.56

1.5

1.4

12.79

13.51

u/l

1.50

424

1392

Primary_lymphoid and hematopoietic malignant neoplasms

281

892

3.20

69.69

1.6

1.4

16.77

12.66

u/l

5.68

271

853

Other respiratory disorders and diseases

258

784

3.35

68.79

1.7

1.4

13.26

13.14

u/l

0.10

251

749

Other diseases of the respiratory system

258

784

3.35

68.79

1.7

1.4

13.26

13.14

u/l

0.10

251

749

Symptoms and signs involving the circulatory and respiratory systems

600

1299

2.33

67.89

1.5

1.4

12.35

12.65

u/l

0.45

579

1265

COPD, hospital admissions 3, with asthma pneumonia sepsis

342

1037

2.87

67.54

1.5

1.4

12.58

13.71

u/l

2.35

328

995

Malaise and fatigue

416

1269

2.60

67.21

1.4

14.04

12.53

u/l

3.26

401

1230

Atrial fibrillation and flutter with reimbursement

188

263

4.55

65.98

1.4

14.06

10.76

u/l

5.85

178

255

Diseases of arteries, arterioles and capillaries (FINNGEN)

174

258

4.70

65.71

1.5

1.4

13.17

10.91

u/l

3.72

165

250

Secondary and unspecified malignant neoplasm of lymph nodes

106

168

6.47

64.03

1.7

1.4

15.73

13.57

u/l

1.09

101

160

Cardiovascular diseases (excluding rheumatic etc)

291

512

3.27

63.89

1.6

1.4

12.59

10.88

u/l

2.93

280

504

Autoimmune diseases excluding thyroid diseases

714

1871

2.08

63.31

1.5

1.4

13.80

12.46

u/l

4.13

678

1818

ILD, hospital admission 2, with pulmonary infections

128

246

5.33

63.21

1.6

1.4

13.79

12.42

u/l

1.22

123

240

Other disorders of fluid, electrolyte and acid-base balance

323

1094

2.81

63.19

1.5

1.4

13.76

13.15

u/l

0.75

312

1050

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

157

359

4.45

62.89

1.5

1.4

14.28

13.26

u/l

0.61

152

344

Polyarthropathies

522

1463

2.31

62.20

1.5

1.4

14.01

12.55

u/l

3.62

506

1417

Autoimmune diseases excluding thyroid diseases, strict definition

691

1809

2.09

62.07

1.5

1.4

13.84

12.51

u/l

3.88

656

1758

Common variable immunodeficiency

164.70

60.20

3.1

1.2

16.16

12.80

u/l

—

Any reimbursement code in KELA

243

333

3.67

59.93

1.7

1.2

12.47

11.65

u/l

0.78

235

327

Tramadol

508

1329

2.31

59.82

1.5

1.4

13.09

12.81

u/l

0.33

491

1285

Opioids

586

1375

2.21

59.76

1.5

1.4

12.27

12.76

u/l

0.87

566

1331

337

1277

2.64

59.20

1.5

1.4

12.18

13.01

u/l

1.22

326

1237

Cardiac arrhythmias

328

746

2.83

59.19

1.4

12.80

11.03

u/l

3.97

317

723

Haemorrhage from respiratory passages

300

961

2.79

57.15

1.4

13.90

13.20

u/l

0.81

283

931

Pulmonary heart disease, diseases of pulmonary circulation

321

1232

2.64

56.14

1.5

1.4

11.92

13.37

u/l

3.50

313

1183

Acute tubulo-interstitial nephritis

461

1741

2.25

55.32

1.4

14.06

12.45

u/l

4.00

440

1691

Cardiomyopathy

162

426

3.85

53.72

1.6

1.3

13.51

11.88

u/l

2.51

156

413

Conduction disorders

242

648

3.02

51.94

1.6

1.4

13.86

11.93

u/l

4.12

233

626

Other arrhythmias

363

1108

2.46

51.93

1.4

13.09

11.73

u/l

3.54

355

1077

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

127

181

5.00

51.54

1.6

1.3

13.34

11.23

u/l

2.31

120

173

Other acute lower respiratory infections

423

1840

2.20

49.56

1.5

1.4

12.98

13.05

u/l

0.08

408

1777

Neoplasms

374

795

2.48

49.36

1.7

1.4

12.49

12.72

u/l

0.22

364

766

Metabolic disorders

610

1855

1.98

49.08

1.5

1.4

13.10

12.65

u/l

0.76

592

1792

Bronchitis

716

2301

1.87

48.97

1.5

1.4

12.98

12.84

u/l

0.19

692

2224

AV-block

174

425

3.54

48.92

1.4

1.3

14.03

11.96

u/l

3.40

166

410

Cardiovascular diseases

249

434

3.06

48.20

1.6

1.4

12.67

10.93

u/l

2.58

241

428

Codeine

526

1363

2.09

47.79

1.3

1.4

13.12

12.75

u/l

0.49

508

1320

Asthma (diagnoses ohter than nonallergic)

586

2449

1.94

47.47

1.5

1.4

12.25

13.04

u/l

2.00

571

2363

Complications of surgical and medical care, not elsewhere classified

661

2350

1.88

47.13

1.5

1.4

13.24

12.79

u/l

0.85

637

2274

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

611

1999

1.94

46.87

1.5

1.4

13.57

12.34

u/l

2.76

587

1936

Pulmonary embolism

281

1107

2.57

46.69

1.5

1.4

11.58

13.32

u/l

4.29

273

1061

Hypertensive heart and/or renal disease

255

675

2.79

46.34

1.4

14.65

12.07

u/l

6.64

247

653

Pulmonary heart disease

281

1114

2.55

46.09

1.5

1.4

11.58

13.31

u/l

4.24

273

1068

712

1948

1.86

45.71

1.5

1.4

12.98

12.92

u/l

0.06

687

1880

Common variable immunodeficiency with predominant abnormalities of B-cell numbers and function

+∞

45.68

3.4

0.0

18.38

—

u/l

—

Venous thromboembolism

437

2014

2.10

45.62

1.5

1.4

12.14

13.37

u/l

2.96

417

1946

DVT of lower extremities and pulmonary embolism

359

1598

2.26

44.87

1.5

1.4

12.07

13.29

u/l

2.39

344

1542

Autoimmune diseases

687

1875

1.87

44.64

1.5

1.4

13.47

12.46

u/l

2.58

659

1822

Pain in throat and chest

460

1285

2.13

44.64

1.5

1.4

12.48

12.66

u/l

0.22

443

1251

Iron deficiency anaemia

363

1606

2.24

44.25

1.5

1.4

14.16

13.01

u/l

1.87

346

1551

Asthma/COPD (KELA code 203)

579

2016

1.93

44.21

1.4

12.04

13.02

u/l

3.03

563

1949

L04AX Other immunosuppressants

373

1710

2.19

43.71

1.4

13.65

12.58

u/l

1.46

361

1661

Oedema, not elsewhere classified

257

977

2.59

43.53

1.7

1.4

13.85

12.52

u/l

2.16

249

948

Second line medication for Crohn's disease

378

1747

2.17

43.34

1.4

13.67

12.56

u/l

1.56

366

1695

L04AA Selective immunosuppressants

176

569

3.13

42.46

1.5

14.46

12.17

u/l

3.38

171

551

Diseases of arteries, arterioles and capillaries

518

1960

1.95

41.69

1.4

14.22

12.96

u/l

3.19

495

1894

Enterocolitis due to Clostridium difficile

130

353

3.75

41.43

1.7

1.4

13.96

13.56

u/l

0.24

125

332

Caries of dentine

201

683

2.87

41.26

1.7

1.4

14.32

13.33

u/l

0.83

194

660

Acute bronchitis

332

1461

2.25

41.03

1.5

1.4

13.06

13.22

u/l

0.15

322

1410

Hypertensive diseases (excluding secondary)

221

446

2.89

40.45

1.6

1.4

12.86

10.89

u/l

2.95

212

438

Dental caries

217

760

2.72

40.18

1.7

1.4

14.36

13.22

u/l

1.09

209

733

Malignant neoplasm of skin

311

894

2.37

40.18

1.4

1.5

14.16

13.45

u/l

0.81

300

858

Complications of procedures, not elsewhere classified

539

2312

1.89

40.17

1.5

1.4

13.13

12.82

u/l

0.47

519

2236

Cough

264

1006

2.46

40.04

1.7

1.4

12.67

12.80

u/l

0.11

255

980

Care involving use of rehabilitation procedures

369

1558

2.14

39.96

1.6

1.4

12.79

12.60

u/l

0.20

345

1511

Used for control exclusion in common control thyroid runs

634

1738

1.85

39.86

1.5

1.4

13.14

12.51

u/l

1.24

612

1688

Malignant neoplasm of skin, including Hilmo

317

919

2.32

39.17

1.4

14.04

13.45

u/l

0.63

305

882

Other and unspecified iron deficiency

287

1236

2.34

39.12

1.5

1.4

14.15

12.84

u/l

1.81

276

1192

Pacemaker

353

1536

2.16

38.98

1.4

14.22

13.36

u/l

1.52

338

1476

Nutritional anaemias

401

1881

2.05

38.89

1.5

1.4

14.04

13.07

u/l

1.59

383

1820

Bleeding

566

2160

1.85

38.38

1.4

14.11

12.69

u/l

4.06

543

2097

Implicit fungal Sepsis, including avohilmo

174

4.93

38.21

1.5

1.4

14.33

12.10

u/l

1.62

166

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

193

411

2.97

37.95

1.7

1.4

13.72

10.81

u/l

4.22

185

403

Explicit bacterial Sepsis, including avohilmo

116

311

3.79

37.65

1.3

1.4

15.07

12.20

u/l

4.36

110

299

Intestinal infectious diseases

594

2463

1.80

37.62

1.5

1.4

13.79

12.66

u/l

3.07

569

2387

Diseases of oesophagus, stomach and duodenum

650

2168

1.78

37.57

1.5

1.4

13.31

12.61

u/l

1.49

627

2100

Complications of medical and surgical care

498

2391

1.88

37.53

1.5

1.4

13.06

12.92

u/l

0.17

477

2313

Explicit bacterial Sepsis

115

308

3.80

37.39

1.3

1.4

15.15

12.23

u/l

4.46

109

296

Certain infectious and parasitic diseases, including avohilmo

393

922

2.14

37.26

1.6

1.4

13.29

11.72

u/l

3.88

379

890

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

296

860

2.34

37.13

1.4

1.5

14.38

13.45

u/l

1.11

284

825

Non-small cell lung cancer, squamous

127

5.66

36.99

1.4

1.3

11.56

15.23

u/l

3.98

120

Other bacterial intestinal infections

175

613

2.89

36.77

1.7

1.4

13.98

12.83

u/l

1.23

169

587

STROKE

347

1083

2.17

36.55

1.4

13.12

11.85

u/l

2.42

333

1048

Presence of cardiac and vascular implants and grafts

385

1381

2.07

36.44

1.5

1.4

14.49

12.92

u/l

4.45

369

1325

Reimbursement for rheumatic diseases

371

1812

2.05

36.37

1.4

13.25

12.68

u/l

0.72

358

1759

Adjustment and management of implanted device

173

606

2.89

36.36

1.4

14.49

13.19

u/l

1.53

164

581

Basal cell carcinoma

281

815

2.37

36.33

1.4

1.5

14.51

13.54

u/l

1.10

269

782

Agranulocytosis

110

292

3.83

36.25

1.4

1.5

13.87

12.76

u/l

0.32

110

280

Basal cell carcinoma, including Hilmo

289

844

2.33

36.17

1.4

14.36

13.50

u/l

0.95

275

809

Persons encountering health services in other circumstances, wide

699

2078

1.73

36.12

1.5

1.4

13.06

12.81

u/l

0.35

685

2002

Glomerular diseases

173

609

2.88

36.05

1.6

1.4

16.23

12.85

u/l

4.86

164

587

Later onset COPD

304

1107

2.23

35.43

1.4

13.12

13.73

u/l

0.93

292

1059

Diarrhoea and gastroenteritis of presumed infectious origin

446

2105

1.90

34.73

1.5

1.4

13.59

12.69

u/l

1.62

427

2040

Infections of the skin and subcutaneous tissue

379

1878

2.00

34.65

1.6

1.4

14.15

12.57

u/l

2.19

368

1821

Systemic connective tissue disorders

262

1150

2.30

34.41

1.4

13.49

13.06

u/l

0.39

248

1112

Autoimmune diseases related-to ILD

518

2396

1.81

34.37

1.5

1.4

13.24

12.72

u/l

0.83

492

2326

Other malignant neoplasms of skin (=non-melanoma skin cancer)

282

836

2.30

34.35

1.4

1.5

14.43

13.51

u/l

1.05

269

801

Bacterial intestinal infections, IBD co-morbidities

172

622

2.80

34.09

1.7

1.4

13.92

12.81

u/l

1.28

167

592

Persons encountering health services for other counselling and medical advice, not elsewhere classified

665

2062

1.72

33.61

1.5

1.4

13.29

12.80

u/l

0.87

651

1987

Other bacterial intestinal infections, including avohilmo

197

770

2.58

33.46

1.6

1.4

13.67

12.90

u/l

0.77

188

740

Hypertensive Heart Disease

215

647

2.55

33.26

1.5

1.4

14.31

12.07

u/l

6.27

208

626

Early onset COPD

192

745

2.61

33.15

1.5

1.4

11.58

12.93

u/l

2.29

187

721

Streptococcal septicaemia, including avohilmo

256

3.90

33.10

1.4

15.12

12.67

u/l

2.68

242

Asthma, hospital admissions , main diagnosis only

500

2417

1.81

33.08

1.5

1.4

12.38

12.93

u/l

0.98

486

2337

Hypo-osmolality and hyponatraemia

167

601

2.79

32.87

1.4

12.88

13.20

u/l

0.24

161

571

Streptococcal septicaemia

253

3.90

32.84

1.4

15.21

12.62

u/l

2.94

240

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

149

225

3.33

32.48

1.4

13.12

11.79

u/l

1.08

141

218

Other respiratory diseases principally affecting the interstitium

188

732

2.60

32.30

1.6

1.4

14.11

13.40

u/l

0.58

180

704

COPD, hospital admissions 1, only main diagnosis

319

1339

2.07

31.20

1.5

1.4

12.53

13.48

u/l

1.92

307

1287

L01XE Protein kinase inhibitors

160

4.70

31.19

1.4

11.55

13.41

u/l

1.53

152

Gout

265

1036

2.22

31.00

1.5

1.4

14.66

13.06

u/l

2.69

253

998

Glomerular disorders in diseases classified elsewhere

122

386

3.21

30.78

1.5

1.4

17.89

12.88

u/l

5.81

114

373

Malignant neoplasm of breast, HER2-negative, including Hilmo

178

420

2.73

30.35

1.4

11.34

12.80

u/l

2.62

173

406

Malignant neoplasm of breast, including Hilmo

178

420

2.73

30.35

1.4

11.34

12.80

u/l

2.62

173

406

Diagnoses used for exclusion with ILD

218

935

2.35

30.33

1.6

1.4

14.18

13.13

u/l

0.96

213

896

Other diseases of intestines

594

1943

1.71

29.78

1.5

1.4

13.00

12.65

u/l

0.39

569

1889

Malignant neoplasm of breast

175

417

2.72

29.73

1.4

11.48

12.84

u/l

2.25

170

403

Type 2 diabetes, wide definition

496

1765

1.78

29.41

1.5

1.4

14.84

12.18

u/l

9.96

474

1714

Malignant neoplasm of breast, HER2-negative

174

417

2.70

29.27

1.4

11.48

12.84

u/l

2.23

169

403

Other disorders of skin and subcutaneous tissue

483

2326

1.76

29.20

1.6

1.4

13.99

12.84

u/l

2.82

456

2257

Other special examinations and investigations of persons without complaint or reported diagnosis

383

992

1.96

29.12

1.6

1.3

13.13

12.51

u/l

0.88

372

966

Examination and observation for other reasons

346

974

2.01

28.97

1.5

1.3

13.29

12.50

u/l

1.00

336

949

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

251

3.70

28.52

1.9

1.5

13.49

13.33

u/l

0.07

240

Malignant neoplasm of digestive organs, including Hilmo

254

854

2.20

28.42

1.4

13.42

13.46

u/l

0.03

248

819

Codeine or tramadol medication

651

2156

1.64

28.24

1.4

13.21

12.70

u/l

0.94

628

2086

malignant neoplasm of female genital organs, including Hilmo

266

3.50

28.02

1.3

1.5

10.46

13.32

u/l

4.30

255

Hypertension, essential

389

1159

1.90

27.89

1.5

1.4

13.47

11.62

u/l

4.85

372

1130

Parasetamol

367

950

1.96

27.78

1.5

1.4

12.96

12.54

u/l

0.51

351

927

Insulin medication

408

1866

1.82

27.67

1.6

1.4

16.74

12.39

u/l

19.94

379

1808

Diseases of the skin and subcutaneous tissue

561

1654

1.71

27.44

1.5

1.4

13.17

12.28

u/l

2.01

541

1604

Coagulation defects, purpura and other haemorrhagic conditions

157

612

2.59

26.94

1.6

1.5

16.15

12.79

u/l

3.16

152

589

ILD, hospital admissions

159

625

2.58

26.91

1.7

1.4

13.75

13.15

u/l

0.48

153

600

Use of hypnotics and sedatives

621

2175

1.64

26.76

1.4

12.38

12.98

u/l

1.37

598

2107

General examination and investigation of persons without complaint and reported diagnosis

366

989

1.93

26.70

1.5

1.3

13.28

12.50

u/l

0.71

351

963

Other interstitial pulmonary diseases

160

634

2.56

26.63

1.7

1.4

13.75

13.11

u/l

0.52

153

610

Diabetic nephropathy, excluding more controls

137

400

2.83

26.46

1.4

17.71

13.72

u/l

4.55

126

389

ILD medications: azathioprine

278

3.41

26.41

1.5

1.4

13.90

12.32

u/l

0.99

273

Interstitial lung disease

160

637

2.55

26.38

1.7

1.4

13.75

13.09

u/l

0.54

153

613

Interstitial lung disease endpoints

160

637

2.55

26.38

1.7

1.4

13.75

13.09

u/l

0.54

153

613

Disorders of lipoprotein metabolism and other lipidaemias

494

1748

1.72

26.20

1.5

1.4

13.24

12.79

u/l

0.66

478

1686

Gout, FINNGEN

265

1296

2.05

26.17

1.5

1.4

14.66

13.25

u/l

2.17

253

1247

Medical observation and evaluation for suspected diseases and conditions

369

992

1.91

26.01

1.6

1.3

12.65

12.51

u/l

0.14

356

966

Implicit fungal Sepsis

100

5.34

25.89

1.5

1.4

15.96

11.73

u/l

2.45

Constipation

553

2270

1.66

25.84

1.5

1.4

12.77

13.02

u/l

0.36

533

2198

Calcific aortic valvular stenosis

276

1332

2.01

25.78

1.5

1.4

15.56

13.28

u/l

2.97

264

1276

Calcific aortic valvular stenosis, operated

276

1332

2.01

25.78

1.5

1.4

15.56

13.28

u/l

2.97

264

1276

Operations 2 for CAVS

276

1332

2.01

25.77

1.5

1.4

15.56

13.28

u/l

2.97

264

1276

Calcific aortic valvular stenosis, diagnosis (helper)

276

1332

2.01

25.77

1.5

1.4

15.56

13.28

u/l

2.97

264

1276

Hard cardiovascular diseases

465

1577

1.75

25.73

1.5

1.4

13.53

12.44

u/l

1.62

448

1524

Other systemic involvement of connective tissue (FG)

185

781

2.34

25.55

1.4

13.36

12.89

u/l

0.36

177

754

malignant neoplasm of female genital organs

235

3.57

25.45

1.3

10.46

13.40

u/l

3.82

224

Fungal Sepsis

109

5.08

25.45

1.5

1.3

17.92

12.16

u/l

2.32

103

Calcific aortic valvular stenosis, including rheumatic fever

276

1338

2.00

25.37

1.5

1.4

15.56

13.27

u/l

2.98

264

1282

Acute upper respiratory infections of multiple and unspecified sites

433

1807

1.75

25.32

1.5

1.4

12.97

12.77

u/l

0.21

421

1748

Azathioprine

286

3.32

25.27

1.5

1.4

13.90

12.59

u/l

0.75

281

Symptoms and signs involving the digestive system and abdomen

569

1723

1.66

25.16

1.5

1.4

13.28

12.64

u/l

0.92

545

1672

Peripheral artery disease

359

1551

1.84

24.90

1.4

15.24

13.09

u/l

5.40

340

1491

Other soft tissue disorders, not elsewhere classified

543

1864

1.66

24.85

1.5

1.4

12.83

12.82

u/l

0.00

518

1805

Diseases of the digestive system

340

1845

1.84

24.53

1.5

1.4

14.58

13.18

u/l

2.70

326

1780

Malignant neoplasm, without specification of site, including Hilmo

101

5.14

24.50

1.3

1.2

13.30

15.28

u/l

0.77

Symptoms and signs involving the urinary system

483

2174

1.68

24.46

1.4

12.87

12.98

u/l

0.14

468

2100

Finngen Rheumatological endpoints

519

1766

1.67

24.36

1.5

1.4

12.63

12.54

u/l

0.09

502

1710

Unspecified acute lower respiratory infection

124

453

2.77

24.26

1.7

1.5

12.99

12.84

u/l

0.09

117

434

Cerebrovascular diseases

489

2028

1.68

24.21

1.4

13.56

12.98

u/l

1.05

467

1966

Other systemic involvement of connective tissue

197

893

2.22

24.15

1.5

1.4

13.37

13.22

u/l

0.09

188

860

Nausea and vomiting

185

795

2.28

24.12

1.6

1.4

14.10

12.89

u/l

1.35

176

769

Hypertensive diseases

379

1175

1.82

23.98

1.5

1.4

13.30

11.61

u/l

4.05

365

1145

Acute sinusitis

276

1284

1.96

23.98

1.7

1.4

12.66

12.48

u/l

0.15

268

1242

Malignant neoplasm of digestive organs

228

822

2.13

23.97

1.4

13.25

13.54

u/l

0.30

223

788

Pure hypercholesterolaemia

457

1704

1.71

23.77

1.4

13.54

12.81

u/l

1.18

441

1642

Hypertension

378

1175

1.82

23.71

1.5

1.4

13.32

11.61

u/l

4.16

364

1145

Diseases of liver

239

1182

2.04

23.36

1.6

1.4

17.26

12.49

u/l

9.76

229

1143

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

390

2207

1.74

23.36

1.5

1.4

13.17

12.95

u/l

0.26

375

2137

Rheumatoid arthritis, including avohilmo

247

1238

2.01

23.26

1.4

13.98

12.98

u/l

1.02

242

1191

Ulcer of lower limb, not elsewhere classified

138

545

2.56

23.18

1.5

1.4

15.52

13.19

u/l

2.85

132

526

Chronic sinusitis

257

1309

1.97

22.99

1.7

1.4

11.83

12.76

u/l

1.49

250

1269

Asthma, including avohilmo

664

2362

1.55

22.89

1.5

1.4

12.35

13.05

u/l

1.73

644

2281

Substance abuse, excluding more controls

351

1644

1.79

22.68

1.3

1.4

12.40

13.18

u/l

1.29

339

1592

Antihypertensive medication - note that there are other indications

229

557

2.15

22.56

1.6

1.4

12.48

11.29

u/l

1.41

220

543

Abnormal findings on examination of blood, without diagnosis

352

1800

1.78

22.49

1.6

1.4

13.46

13.11

u/l

0.41

333

1740

Insulin, fast-acting

246

1246

1.99

22.46

1.5

1.4

17.39

12.49

u/l

13.68

228

1209

Osteopathies and chondropathies

345

1776

1.78

22.28

1.6

1.4

13.16

12.88

u/l

0.30

333

1719

Osteoporosis

196

837

2.17

22.27

1.7

1.4

12.63

13.53

u/l

1.08

190

796

Intestinal infectious diseases, including avohilmo, including avohilmo

653

2359

1.55

22.18

1.4

13.76

12.63

u/l

3.28

627

2285

Small cell lung cancer

6.34

22.01

1.4

1.2

12.41

14.73

u/l

1.21

Small cell lung cancer, including Hilmo

6.34

22.01

1.4

1.2

12.41

14.73

u/l

1.21

Childhood asthma (age<16), excluding more controls

8.36

21.94

1.7

1.4

11.84

12.23

u/l

0.09

Obesity related asthma

216

1055

2.06

21.88

1.6

1.4

12.72

12.93

u/l

0.15

208

1022

Cardiodefibrillation

287

1543

1.87

21.81

1.4

15.07

12.93

u/l

2.64

279

1485

Insulin, combination of fast acting with intermediate-acting or long-acting

408

2204

1.69

21.58

1.6

1.4

16.74

12.64

u/l

18.21

379

2143

Drug-induced neutropenia

188

3.68

21.33

1.4

12.15

13.28

u/l

0.38

179

Syncope and collapse

273

1215

1.88

20.78

1.4

13.47

12.55

u/l

1.50

257

1175

Percutaneous Coronary Intervention

442

1620

1.66

20.78

1.4

13.83

12.43

u/l

2.29

425

1562

Ischemic heart diseases

455

1648

1.65

20.54

1.5

1.4

13.62

12.40

u/l

1.86

435

1590

Factors influencing health status and contact with health services

153

310

2.49

20.48

1.4

1.3

14.12

11.68

u/l

3.28

144

303

Insulin, fast-acting or short human

248

1302

1.92

20.43

1.5

1.4

17.34

12.66

u/l

12.81

230

1259

Childhood asthma (age<16)

7.60

20.41

1.7

1.4

11.84

12.42

u/l

0.14

Abnormalities of heart beat

195

921

2.06

19.82

1.5

1.4

12.55

12.75

u/l

0.17

189

895

Disorders of lens

400

1479

1.68

19.72

1.4

13.92

12.34

u/l

3.77

381

1433

Pain in limb

465

1835

1.61

19.63

1.5

1.4

13.19

12.81

u/l

0.51

438

1776

Benign neoplasm of colon, rectum, anus and anal canal

423

2201

1.63

19.55

1.4

13.41

13.12

u/l

0.40

412

2119

Insulin, intermediate and long-acting

361

2070

1.69

19.52

1.5

1.4

17.16

12.66

u/l

18.65

336

2011

ILD, hospital admissions 1, main diag only

132

556

2.41

19.42

1.6

1.4

14.13

13.22

u/l

0.73

126

534

Coronary revascularization (ANGIO or CABG)

436

1621

1.64

19.35

1.4

13.83

12.43

u/l

2.26

419

1563

Viral infections characterized by skin and mucous membrane lesions

254

1369

1.86

19.30

1.6

1.4

13.29

12.89

u/l

0.33

241

1330

GI-bleeding

253

1369

1.86

19.07

1.5

1.4

14.98

13.24

u/l

2.68

240

1317

Emergency coronary revascularization (for ACS)

490

1870

1.59

19.07

1.4

13.75

12.63

u/l

1.86

473

1803

Other and unspecified dermatitis

313

1807

1.74

18.94

1.6

1.4

13.86

12.69

u/l

2.18

302

1748

Volume depletion

324

2.84

18.83

1.7

1.4

15.06

13.18

u/l

0.99

308

Non-small cell lung cancer, squamous, helper endpoint

215

3.33

18.78

1.4

11.56

13.97

u/l

2.97

202

Other diseases of the digestive system

251

1362

1.86

18.78

1.5

1.4

14.82

13.19

u/l

2.38

239

1310

Endocrine, nutritional and metabolic diseases

366

1077

1.72

18.68

1.5

1.4

12.94

11.70

u/l

2.39

356

1046

Diabetes mellitus

528

1967

1.55

18.64

1.5

1.4

14.22

11.91

u/l

8.32

505

1914

Dermatitis

369

2191

1.65

18.43

1.6

1.4

13.67

12.68

u/l

2.02

357

2116

Diabetes, varying definitions

525

1967

1.55

18.42

1.5

1.4

14.22

11.92

u/l

8.18

502

1914

Headache

294

1282

1.78

18.39

1.6

1.4

12.34

12.27

u/l

0.06

285

1245

Gout, idiopatic and unspecified

217

1132

1.93

18.39

1.5

1.4

14.37

13.07

u/l

2.00

211

1090

Atherosclerosis, excluding cerebral and coronary sclerosis

325

1488

1.73

18.33

1.4

14.87

13.12

u/l

3.60

307

1433

Dipeptidyl peptidase 4 (DPP-4) inhibitors

378

1801

1.65

18.21

1.5

1.4

16.06

12.64

u/l

11.33

356

1737

Iron deficiency anaemia secondary to blood loss (chronic)

127

541

2.37

18.20

1.4

14.82

13.15

u/l

1.91

117

520

Type 2 diabetes

518

1938

1.55

18.17

1.5

1.4

14.13

11.88

u/l

7.78

495

1885

Senile cataract

386

1419

1.66

18.04

1.4

13.70

12.42

u/l

2.67

365

1374

Other CVD

174

847

2.07

17.95

1.6

1.4

14.47

13.59

u/l

0.87

166

810

Mental and behavioural disorders due to psychoactive substance use

361

2010

1.65

17.80

1.3

1.4

12.41

13.00

u/l

0.92

349

1946

Gastroduodenal ulcer

208

1083

1.93

17.55

1.5

1.4

14.59

13.15

u/l

1.73

200

1047

Substance abuse

351

1978

1.65

17.50

1.3

1.4

12.40

13.01

u/l

0.94

339

1914

Fitting and adjustment of other devices

226

1062

1.88

17.45

1.5

1.4

13.88

13.12

u/l

0.90

215

1026

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

553

2359

1.51

17.37

1.4

13.49

12.62

u/l

1.89

530

2285

Stroke, including SAH

418

1884

1.60

17.37

1.4

13.45

13.01

u/l

0.63

398

1824

Misadventures to patients during surgical and medical care

107

431

2.51

17.36

1.5

12.98

12.97

u/l

0.01

102

416

Polyneuropathies and other disorders of the peripheral nervous system

172

849

2.04

17.12

1.5

1.4

13.68

13.27

u/l

0.27

161

818

Injuries to the head

595

2391

1.48

16.87

1.4

13.25

12.73

u/l

0.89

573

2317

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

348

2135

1.63

16.65

1.6

1.4

13.11

12.96

u/l

0.16

334

2064

Hodgkin lymphoma, hilmo

5.37

16.62

1.5

1.4

15.06

13.50

u/l

0.25

Other neurological diseases

450

2260

1.55

16.61

1.5

1.4

13.32

13.06

u/l

0.33

433

2183

Hyperlipidaemia, other/unspecified

270

1393

1.75

16.50

1.5

1.4

13.75

13.13

u/l

0.91

257

1337

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

543

2302

1.49

16.39

1.6

1.4

13.80

12.73

u/l

2.38

518

2232

Diabetic nephropathy

138

629

2.19

16.39

1.4

1.5

17.66

14.24

u/l

3.85

127

605

Intracranial trauma

283

1098

1.75

16.33

1.5

1.4

13.39

12.55

u/l

0.91

270

1066

Convulsions, not elsewhere classified

126

553

2.26

16.33

1.6

1.4

12.87

12.41

u/l

0.34

120

539

Benign neoplasms

520

1871

1.52

16.31

1.5

1.4

12.70

12.75

u/l

0.06

507

1802

Major coronary heart disease event

458

1772

1.55

16.22

1.4

13.87

12.54

u/l

2.17

437

1712

Peripheral arterial reconstruction

156

759

2.08

16.20

1.4

15.59

13.16

u/l

2.94

147

732

Persons encountering health services for examination and investigation

334

992

1.69

16.19

1.5

1.3

13.30

12.51

u/l

1.12

319

966

Respiratory tuberculosis, confirmed, including avohilmo

5.26

16.12

1.5

1.3

15.55

13.77

u/l

0.53

Nonischemic cardiomyopathy

336

2.65

15.97

1.4

12.13

12.37

u/l

0.14

326

Coronary atherosclerosis

376

1479

1.61

15.75

1.5

1.4

14.52

12.54

u/l

5.53

363

1425

Stroke, excluding SAH

400

1841

1.57

15.67

1.4

13.41

13.12

u/l

0.37

380

1780

Other viral diseases, including avohilmo

180

927

1.93

15.38

1.5

1.4

14.42

12.04

u/l

2.57

173

907

Respiratory tuberculosis, confirmed

5.18

15.38

1.4

1.3

15.63

13.83

u/l

0.52

Disorders of choroid and retina

483

2254

1.50

15.36

1.4

14.02

12.90

u/l

2.50

461

2183

Ischaemic Stroke, excluding all haemorrhages

384

1799

1.58

15.24

1.4

13.58

13.20

u/l

0.53

366

1739

Gout, unspecified

176

914

1.94

15.23

1.5

1.4

14.26

13.10

u/l

1.43

171

882

Viral infections of the central nervous system

151

3.48

15.23

1.5

12.48

13.29

u/l

0.27

143

Other viral diseases

146

707

2.07

15.15

1.6

1.5

14.66

12.30

u/l

2.03

140

692

Symptoms and signs involving the skin and subcutaneous tissue

398

2437

1.55

15.10

1.5

1.4

12.43

12.90

u/l

0.77

384

2359

Secondary right heart disease

138

3.63

15.09

1.6

1.4

14.06

14.24

u/l

0.06

130

Cellulitis

144

700

2.07

14.98

1.8

1.4

13.90

12.69

u/l

1.18

139

675

Amputation

395

2.46

14.97

1.6

1.4

16.15

13.02

u/l

2.46

380

Respiratory tuberculosis, bacteriologically and histologically confirmed

5.01

14.85

1.4

1.3

15.63

13.80

u/l

0.53

Benzodiazepine use

544

2522

1.46

14.81

1.4

12.00

13.07

u/l

3.13

521

2442

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

483

1913

1.50

14.79

1.5

1.4

15.34

11.93

u/l

13.61

461

1861

Gastrointestinal diseases

242

674

1.80

14.63

1.6

1.4

13.03

11.96

u/l

1.34

233

660

Other retinal disorders

411

2040

1.54

14.62

1.4

14.40

13.09

u/l

3.01

391

1972

Open wound of head

337

1993

1.59

14.58

1.4

13.51

13.06

u/l

0.55

327

1929

Noninfective enteritis and colitis

254

1491

1.71

14.56

1.5

1.4

13.60

12.78

u/l

0.90

243

1444

Viral infections of the central nervous system, including avohilmo

166

3.29

14.48

1.5

12.33

13.22

u/l

0.31

157

Other and unspecified polyneuropathies, also in other diseases

151

758

2.01

14.44

1.5

1.4

13.80

13.06

u/l

0.56

143

728

346

1959

1.58

14.43

1.4

13.54

12.86

u/l

0.91

332

1896

Other pulmonary heart/vessel disease

157

3.38

14.41

1.6

1.4

13.81

14.16

u/l

0.13

149

Type 1 diabetes, wide definition, subgroup 1

114

514

2.23

14.34

1.4

17.36

11.91

u/l

12.05

103

502

Hernia

495

2233

1.48

14.30

1.4

12.46

12.95

u/l

0.88

485

2154

Acute upper respiratory infections

561

2339

1.44

14.01

1.5

1.4

12.87

12.91

u/l

0.05

541

2260

Fall on same level

573

2126

1.44

13.95

1.4

13.05

12.63

u/l

0.61

550

2067

Symptoms and signs involving cognition, perception, emotional state and behaviour

516

2376

1.45

13.83

1.5

1.4

12.99

12.81

u/l

0.22

495

2306

Other necrotizing vasculopathies

219

2.92

13.76

1.5

12.88

13.21

u/l

0.14

208

Other cataract

275

1231

1.67

13.74

1.5

1.4

13.95

12.46

u/l

2.88

267

1191

Other noninfective gastroenteritis and colitis

146

739

1.99

13.59

1.5

14.10

12.95

u/l

0.91

141

712

Hypotension

147

749

1.98

13.50

1.6

1.4

14.73

13.49

u/l

1.31

140

716

Other infectious diseases, including avohilmo

283

2.64

13.48

1.7

1.4

14.70

13.60

u/l

0.53

269

Colorectal cancer, including Hilmo

143

672

1.99

13.33

1.4

13.36

13.68

u/l

0.24

138

644

Heart failure and hypertrophic cardiomyopathy

4.92

13.18

1.5

1.4

15.28

13.29

u/l

0.76

Alcohol use disorder, Swedish definition

327

1903

1.57

13.17

1.4

13.71

12.82

u/l

1.27

314

1841

Other antidepressants

560

2008

1.43

12.92

1.4

12.49

13.08

u/l

1.11

537

1947

353

2008

1.53

12.85

1.4

13.50

12.94

u/l

0.69

339

1944

Diverticular disease of intestine

408

1693

1.50

12.83

1.4

13.25

12.84

u/l

0.53

392

1642

Selective deficiency of immunoglobulin A [IgA]y

35.09

12.82

1.9

1.2

13.69

10.60

u/l

—

Clear cell adenocarcinoma of kidney

3.91

12.82

1.3

11.38

13.90

u/l

1.04

Abdominal and pelvic pain

498

1723

1.45

12.69

1.5

1.4

13.12

12.64

u/l

0.54

480

1672

Eosinophilic disease (BM)

32.79

12.62

1.8

1.2

12.00

10.80

u/l

—

Major coronary heart disease event excluding revascularizations

358

1541

1.54

12.61

1.4

14.69

12.67

u/l

5.41

343

1486

Other skin changes

139

712

1.97

12.60

1.5

1.4

13.17

13.21

u/l

0.02

133

683

Fracture of rib(s), sternum and thoracic spine

209

1215

1.73

12.59

1.5

1.4

12.75

13.18

u/l

0.46

204

1168

Type 2 diabetes, definitions combined

475

1902

1.46

12.56

1.5

1.4

13.84

11.92

u/l

5.40

456

1849

Other functional intestinal disorders

267

1499

1.62

12.51

1.5

1.4

12.81

12.84

u/l

0.02

252

1456

Candidiasis, including avohilmo

163

883

1.85

12.45

1.5

1.4

13.25

12.63

u/l

0.41

156

853

Type 2 diabetes, strict (exclude DM1)

477

1916

1.45

12.42

1.5

1.4

13.83

11.92

u/l

5.43

458

1861

Diabetes, insulin treatment (Kela reimbursement)

524

2194

1.42

12.37

1.5

1.4

15.34

12.11

u/l

13.59

500

2129

Gastric ulcer

131

663

1.99

12.31

1.5

1.4

14.55

13.25

u/l

1.11

123

637

Disorders of gallbladder, biliary tract and pancreas

531

2339

1.42

12.24

1.5

1.4

14.02

12.61

u/l

3.06

511

2263

Other disorders of adrenal gland

3.84

12.20

2.3

1.4

12.89

12.83

u/l

0.01

Mycoses

171

947

1.82

12.19

1.5

1.4

13.72

12.80

u/l

0.71

160

912

Zoster [herpes zoster]

130

659

1.99

12.17

1.8

1.4

13.00

13.18

u/l

0.11

123

633

Benign neoplasm: Colon

344

2132

1.52

12.15

1.5

1.4

13.51

13.14

u/l

0.48

334

2054

Ehlers-Danlos syndrome, including avohilmo

27.45

12.11

1.6

1.0

9.88

13.17

u/l

—

Type 1 diabetes, wide definition

117

574

2.05

11.94

1.4

17.21

12.01

u/l

11.66

106

560

Diseases of the eye and adnexa

353

1151

1.54

11.88

1.5

1.4

12.71

12.19

u/l

0.65

341

1115

Injuries to the thorax

285

1821

1.57

11.79

1.5

1.4

12.90

13.17

u/l

0.29

277

1757

Other nutritional deficiencies

320

1911

1.53

11.78

1.5

1.4

13.32

12.47

u/l

1.22

313

1855

Other symptoms and signs involving the digestive system and abdomen

423

2.21

11.59

1.5

1.4

13.69

12.58

u/l

0.49

409

Other disorders of skin and subcutaneous tissue, not elsewhere classified

454

2.15

11.29

1.9

1.4

14.60

13.05

u/l

1.36

438

Retention of urine

251

1266

1.61

11.22

1.4

13.77

13.25

u/l

0.59

240

1220

Other viral diseases, not elsewhere classified

447

2.15

11.20

1.6

1.5

13.88

12.71

u/l

0.70

434

Presence of other functional implants

348

1590

1.50

11.17

1.5

1.4

13.89

12.78

u/l

1.38

335

1532

Chronic apical periodontitis

568

2311

1.38

11.16

1.4

12.91

12.83

u/l

0.10

549

2237

Gastro-oesophageal reflux disease

353

2008

1.49

11.12

1.4

12.80

12.65

u/l

0.16

337

1944

Concussion

231

1094

1.64

11.10

1.5

1.4

13.04

12.55

u/l

0.42

220

1062

Any mental disorder

555

2004

1.39

11.09

1.5

1.4

12.09

13.12

u/l

3.17

540

1939

Ischaemic heart disease, wide definition

408

1726

1.46

11.08

1.5

1.4

14.07

12.52

u/l

2.55

391

1666

Exposure to unspecified factor

519

2541

1.39

11.07

1.5

1.4

13.04

12.81

u/l

0.32

502

2457

Type 2 diabetes, definitions combined, including avohilmo

468

1905

1.42

11.03

1.5

1.4

13.76

11.88

u/l

5.28

450

1850

Lung transplant status

16.35

10.97

1.6

1.3

12.88

16.36

u/l

0.49

Lung transplantation

16.35

10.97

1.6

1.3

12.88

16.36

u/l

0.49

Type 1 diabetes

132

697

1.90

10.93

1.4

16.91

12.06

u/l

10.82

122

678

Other viral diseases, not elsewhere classified, including avohilmo

125

645

1.93

10.92

1.5

13.62

12.30

u/l

1.04

119

629

Pain (limb, back, neck, head abdominally)

374

1261

1.49

10.84

1.5

1.4

12.89

12.86

u/l

0.02

359

1227

Mental and behavioural disorders due to alcohol

290

1807

1.53

10.79

1.3

1.4

12.66

12.98

u/l

0.35

279

1746

Small cell lung cancer, helper endpoint

109

3.48

10.76

1.4

12.41

13.99

u/l

0.85

Neurological diseases

397

1361

1.47

10.71

1.5

1.4

12.37

12.73

u/l

0.43

382

1317

Injuries to the hip and thigh

308

1830

1.51

10.71

1.5

1.4

13.39

13.22

u/l

0.16

296

1767

Adrenocortical insufficiency

4.09

10.70

2.6

1.4

13.17

12.90

u/l

0.05

Neurological diseases, wide definition

107

251

2.15

10.65

1.4

12.75

11.20

u/l

1.01

101

243

Other external causes of accidental injury

403

1385

1.46

10.62

1.5

1.4

12.83

12.45

u/l

0.51

385

1345

Diabetes medication

510

2147

1.39

10.55

1.5

1.4

14.52

12.14

u/l

9.28

489

2082

Myocardial infarction

291

1326

1.54

10.49

1.4

14.40

12.65

u/l

3.99

281

1274

Other and unspecified coagulation defects

3.72

10.42

1.5

1.4

13.50

13.81

u/l

0.08

Defects in the complement system

19.78

10.38

1.7

1.1

11.40

11.75

u/l

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

255

1627

1.56

10.31

1.3

1.4

12.87

12.85

u/l

0.01

245

1578

Cerebral palsy and other paralytic syndromes

316

2.33

10.30

1.4

1.5

11.66

13.40

u/l

1.80

305

Phlebitis and thrombophlebitis (not including DVT)

134

728

1.85

10.26

1.7

1.4

13.15

13.01

u/l

0.06

124

703

Injuries to the abdomen, lower back, lumbar spine and pelvis

238

1488

1.58

10.25

1.5

1.4

13.71

13.10

u/l

0.68

230

1429

Dermatitis and eczema

569

2485

1.36

10.24

1.6

1.4

13.50

12.73

u/l

1.77

552

2399

Congenital malformations, deformations and chromosomal abnormalities

251

1529

1.56

10.13

1.7

1.4

11.82

12.52

u/l

0.97

245

1486

Malignant melanoma

377

2.19

10.03

1.4

13.31

13.06

u/l

0.11

361

Other infectious diseases

241

2.52

10.01

1.8

1.4

15.27

13.57

u/l

0.81

229

Symptoms and signs involving the nervous and musculoskeletal systems

316

2147

1.48

9.90

1.4

12.30

12.99

u/l

1.23

304

2076

Other anxiety disorders

184

937

1.67

9.79

1.6

1.4

11.38

12.44

u/l

1.42

178

917

Mental and behavioural disorders due to tobacco

220

2.57

9.77

1.3

1.5

11.84

13.03

u/l

0.63

213

Accidents

397

1385

1.44

9.73

1.5

1.4

12.84

12.45

u/l

0.53

379

1345

Smoking dependency

221

2.56

9.69

1.3

1.5

11.84

13.01

u/l

0.61

213

Fracture of femur

191

1049

1.65

9.63

1.3

1.4

13.80

13.39

u/l

0.31

180

1004

Diseases of the musculoskeletal system and connective tissue

242

763

1.59

9.57

1.5

1.4

13.35

12.40

u/l

1.10

231

743

Alcohol use disorder, ICD-based

234

1507

1.56

9.51

1.4

12.83

12.84

u/l

0.01

225

1462

Genitourinary diseases

272

885

1.54

9.42

1.4

12.94

12.43

u/l

0.54

264

859

Malignant melanoma, including Hilmo

434

2.06

9.38

1.4

13.24

13.10

u/l

0.06

418

Disorders of other endocrine glands

217

1355

1.58

9.38

1.5

1.4

13.18

12.88

u/l

0.24

211

1306

Arthropathies

426

1534

1.41

9.24

1.5

1.4

12.37

12.53

u/l

0.20

409

1488

Intestinal stricture

197

1228

1.61

9.23

1.5

1.4

13.09

13.11

u/l

0.01

189

1181

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

275

1686

1.49

8.96

1.7

1.4

11.91

12.56

u/l

0.95

268

1636

Candidiasis

375

2.12

8.96

1.4

1.5

14.68

12.83

u/l

0.83

360

Falls/tendency to fall

503

1857

1.36

8.90

1.5

1.4

13.10

12.57

u/l

0.83

478

1808

Chronic gastritis

166

1001

1.67

8.90

1.5

1.4

14.31

13.23

u/l

0.98

160

964

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

446

2542

1.37

8.90

1.6

1.4

13.11

12.75

u/l

0.46

428

2461

Type of accident

156

928

1.69

8.80

1.7

1.4

14.88

12.70

u/l

2.08

146

897

Asthma mixed form (mode), excluding more controls

10.72

8.78

1.6

1.1

16.00

14.33

u/l

0.23

Hypertrophic cardiomyopathy

124

3.03

8.76

1.5

1.4

14.41

13.75

u/l

0.22

116

Soft tissue disorders

496

1875

1.36

8.75

1.5

1.4

12.77

12.83

u/l

0.06

482

1816

Osteomyelitis

197

2.57

8.73

1.4

14.89

13.42

u/l

0.63

189

Urticaria and erythema

165

1000

1.65

8.66

1.6

1.4

12.10

12.72

u/l

0.56

158

968

Other gastritis (incl. Duodenitis)

134

770

1.75

8.60

1.8

1.4

15.50

12.93

u/l

3.14

129

741

Unspecified haematuria

271

1491

1.48

8.58

1.5

1.4

13.34

13.26

u/l

0.08

263

1432

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

106

565

1.86

8.36

1.5

11.41

12.31

u/l

0.80

101

549

Fracture of lumbar spine and pelvis

146

865

1.69

8.32

1.6

1.4

14.47

13.27

u/l

1.19

140

827

Supplementary factors related to causes of morbidity and mortality classified elsewhere

164

1008

1.63

8.19

1.7

1.4

14.80

12.63

u/l

2.19

153

974

Unspecified fall

279

1896

1.45

8.03

1.5

1.4

13.39

13.06

u/l

0.31

265

1836

Disorders of sclera, cornea, iris and ciliary body

272

1876

1.45

8.02

1.5

1.4

12.59

12.88

u/l

0.28

259

1823

Pyogenic arthritis

194

2.50

7.98

1.5

13.10

13.45

u/l

0.13

185

Malignant neoplasm of oesophagus, including Hilmo

3.46

7.96

1.1

1.3

11.78

14.27

u/l

1.10

Psychiatric diseases

483

1807

1.34

7.92

1.5

1.4

12.38

13.04

u/l

1.23

470

1750

Other diseases of intestine

519

1.88

7.91

1.4

13.21

12.59

u/l

0.46

498

Dizziness and giddiness

389

2213

1.37

7.88

1.5

1.4

13.12

12.88

u/l

0.32

373

2147

Disorders of eyelid, lacrimal system and orbit

450

2464

1.34

7.87

1.5

1.4

12.38

13.02

u/l

1.40

437

2380

Unspecified privation

302

2.17

7.85

2.0

1.5

13.29

13.26

u/l

0.01

293

Duodenal ulcer

417

1.98

7.80

1.5

1.4

14.68

13.05

u/l

0.97

398

Anxiety disorders, excluding more controls

360

1657

1.39

7.76

1.5

1.4

11.85

13.00

u/l

2.63

348

1605

Sleep apnoea

474

2248

1.33

7.73

1.5

1.4

12.83

12.80

u/l

0.03

456

2175

Obesity due to excess calories

212

1403

1.52

7.70

1.6

1.4

13.48

12.44

u/l

1.22

207

1364

Tuberculosis of other organs

3.79

7.67

1.3

14.26

13.28

u/l

0.32

In situ neoplasms

228

1534

1.49

7.67

1.5

1.4

13.70

13.01

u/l

0.69

222

1478

Obesity

281

1851

1.43

7.61

1.5

1.4

13.51

12.46

u/l

1.49

275

1797

Asthma mixed form (mode)

8.04

7.59

1.6

1.4

16.00

14.55

u/l

0.22

Low back pain

380

1875

1.37

7.59

1.4

13.01

12.80

u/l

0.21

365

1817

Extreme obesity with alveolar hypoventilation

3.13

7.57

2.4

1.4

12.63

13.20

u/l

0.21

Injury, poisoning and certain other consequences of external causes

249

837

1.49

7.53

1.5

1.4

13.32

12.44

u/l

1.06

238

819

Malignant melanoma of skin, including Hilmo

341

2.06

7.49

1.3

1.4

12.94

13.16

u/l

0.09

325

Obesity and other hyperalimentation

282

1862

1.43

7.49

1.5

1.4

13.48

12.47

u/l

1.41

276

1807

Anxiety (asthma-related co-morbidities)

231

1180

1.49

7.48

1.6

1.4

11.19

12.56

u/l

2.64

223

1152

Diabetic retinopathy, excluding more controls

140

462

1.70

7.41

1.4

16.07

13.68

u/l

2.34

135

449

Hepatomegaly and splenomegaly, not elsewhere classified

9.64

7.34

1.1

1.8

16.64

10.87

u/l

2.02

Left bundle-branch block

160

2.58

7.34

1.4

13.20

11.65

u/l

0.98

153

Elevated blood glucose level

221

2.33

7.31

1.3

1.5

15.24

13.18

u/l

1.09

213

External causes of morbidity and mortality

293

1026

1.43

7.21

1.6

1.4

12.94

12.40

u/l

0.63

281

1005

Sequelae of cerebrovascular disease

242

1420

1.46

7.20

1.4

14.27

13.35

u/l

1.28

230

1374

Zoster [herpes zoster], including avohilmo

281

1920

1.42

7.20

1.7

1.4

13.00

12.94

u/l

0.06

270

1859

Coronary artery bypass grafting

181

865

1.56

7.15

1.4

14.93

13.05

u/l

3.52

174

829

Myocardial infarction, strict

260

1276

1.45

7.14

1.4

14.36

12.68

u/l

3.56

252

1225

Episodal and paroxysmal disorders

513

1996

1.31

7.06

1.4

12.78

12.79

u/l

0.01

491

1927

Emotionally unstable personality disorder

188

2.40

6.99

2.0

1.4

10.96

12.21

u/l

0.60

183

Spondyloarthritis

513

1.82

6.94

1.3

1.4

11.97

12.95

u/l

1.02

491

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

159

1014

1.57

6.90

1.4

1.5

12.09

12.92

u/l

0.92

154

982

Intracranial injury

303

2039

1.39

6.90

1.5

1.4

13.66

13.01

u/l

0.69

288

1975

Other symptoms and signs involving cognitive functions and awareness

283

1790

1.41

6.88

1.4

13.49

13.13

u/l

0.33

271

1737

Intestinal adhesions without obstruction

253

2.19

6.87

1.4

12.47

13.17

u/l

0.30

240

Tuberculosis of other organs, strict

3.39

6.86

1.3

14.08

13.61

u/l

0.15

Amyloidosis

3.44

6.73

1.4

13.17

13.57

u/l

0.08

Tuberculosis of other organs, strict, including avohilmo

3.35

6.72

1.3

14.08

13.54

u/l

0.17

Hypothyroidism, strict autoimmune

327

1563

1.37

6.71

1.5

1.4

13.33

12.64

u/l

0.94

319

1520

Diseases of pulp and periapical tissues, including avohilmo

512

2047

1.30

6.70

1.4

12.61

13.03

u/l

0.71

491

1982

All anxiety disorders

234

1257

1.45

6.60

1.5

1.4

11.25

12.60

u/l

2.64

226

1226

Volvulus

3.38

6.57

1.3

1.4

12.57

13.81

u/l

0.35

Transient ischemic attack

308

1786

1.38

6.57

1.4

13.76

13.16

u/l

0.80

296

1730

Dorsalgia

470

1910

1.31

6.57

1.5

1.4

12.68

12.86

u/l

0.22

456

1852

Other (not insulin) diabetes medications

465

2096

1.30

6.56

1.4

14.37

12.13

u/l

7.61

447

2031

Other joint disorders

393

1533

1.34

6.53

1.5

1.4

12.16

12.53

u/l

0.58

378

1487

Other diseases of stomach and duodenum

190

2.34

6.41

1.6

1.5

15.27

12.97

u/l

1.13

182

Hyposplenism

+∞

6.35

1.3

0.0

22.67

—

u/l

—

Covid-19 suspected case

477

1.81

6.34

1.6

1.5

12.50

12.35

u/l

0.08

461

Cholelithiasis, broad definition with cholecystitis

439

2246

1.30

6.31

1.5

1.4

14.27

12.60

u/l

5.08

421

2173

Other condition

374

1.91

6.17

1.6

1.5

14.18

12.82

u/l

0.61

363

Nerve, nerve root and plexus disorders

524

2477

1.27

6.16

1.5

1.4

13.45

12.79

u/l

1.24

496

2405

Visual disturbances and blindness

264

1905

1.39

6.13

1.5

1.4

12.43

12.94

u/l

0.66

254

1841

Pain in joint

268

1177

1.40

6.13

1.6

1.4

13.20

12.68

u/l

0.33

258

1144

Biguanides

461

2158

1.29

6.12

1.4

14.48

12.39

u/l

6.46

444

2087

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

244

1676

1.41

6.11

1.6

1.4

11.82

12.75

u/l

1.90

237

1629

malignant neoplasm of male genital organs, including Hilmo

151

579

1.57

6.05

1.4

1.5

12.43

13.64

u/l

1.72

145

556

Paraplegia, diplegia of upper limbs

3.51

6.04

1.3

1.4

9.95

13.52

u/l

2.72

Spondylopathies

399

1798

1.31

6.02

1.5

1.4

12.68

12.94

u/l

0.22

382

1742

Other symptoms and signs involving the nervous and musculoskeletal systems

203

1408

1.45

5.95

1.4

11.81

12.89

u/l

1.83

196

1364

Sub-endpoint used in defining T1D endpoints

144

919

1.55

5.86

1.4

1.5

17.09

12.75

u/l

9.58

128

893

Neurotic, stress-related and somatoform disorders

369

1936

1.31

5.75

1.5

1.4

11.83

12.86

u/l

2.35

357

1876

Malignant neoplasm of prostate, including Hilmo

149

570

1.55

5.60

1.4

12.41

13.68

u/l

1.84

143

547

Intestinal malabsorption

104

2.72

5.60

2.0

1.4

13.54

13.48

u/l

0.02

Other diseases of upper respiratory tract

534

2218

1.26

5.56

1.5

1.4

12.76

13.04

u/l

0.29

519

2143

Combined immunodeficiencies

5.76

5.42

2.4

1.4

15.14

11.80

u/l

0.79

Failure and rejection of transplanted organs and tissues

6.32

5.41

1.2

1.5

17.23

14.14

u/l

0.50

Exposure to other specified factors

360

2378

1.30

5.41

1.5

1.4

13.28

12.63

u/l

0.59

353

2298

Myeloid leukaemia

2.95

5.32

1.6

1.4

13.48

14.04

u/l

0.12

Alcohol dependence

144

957

1.51

5.31

1.4

1.5

12.69

12.83

u/l

0.08

137

928

Other specific joint derangements/joint disorders

312

1463

1.33

5.26

1.6

1.4

12.91

12.45

u/l

0.35

302

1419

Degeneration of macula and posterior pole

296

1718

1.33

5.21

1.4

13.66

13.24

u/l

0.54

283

1660

Other disorders of lacrimal gland

171

1182

1.45

5.18

1.6

1.4

12.73

13.04

u/l

0.26

166

1140

Other diseases of liver

524

1.69

5.16

1.5

15.26

12.28

u/l

2.70

508

Anxiety disorders

371

1972

1.29

5.14

1.5

1.4

11.81

12.83

u/l

2.34

359

1910

Angina pectoris

284

1406

1.34

5.14

1.5

1.4

14.55

12.54

u/l

2.56

268

1353

Hypersplenism

10.50

5.09

2.2

1.9

24.00

11.22

u/l

—

Use of anticholinesterases

127

1475

0.66

5.06

1.3

1.4

13.92

13.57

u/l

0.27

119

1414

N06DA Anticholinesterases

127

1475

0.66

5.06

1.3

1.4

13.92

13.57

u/l

0.27

119

1414

Malignant neoplasm of oesophagus

3.21

5.05

1.2

1.3

12.00

14.93

u/l

1.00

Other diseases of urinary system

478

2142

1.25

5.04

1.5

1.4

13.66

12.63

u/l

1.51

459

2075

Disorders of lacrimal system

209

1480

1.39

5.04

1.5

1.4

12.85

13.00

u/l

0.13

203

1431

Missing teeth due to accident, extraction or parodontitis

324

2223

1.30

5.01

1.4

12.94

12.99

u/l

0.04

315

2145

Diaphragmatic hernia

189

1340

1.41

5.00

1.4

12.72

13.25

u/l

0.57

180

1289

Atrial septal defect

3.28

4.97

1.8

1.4

13.39

14.24

u/l

0.12

Disorders of calcium metabolism

173

2.21

4.97

1.3

1.4

17.76

12.98

u/l

1.30

165

Allergic urticaria

167

2.23

4.93

2.2

1.4

13.81

12.97

u/l

0.26

159

Mycoses, including avohilmo

424

2563

1.26

4.92

1.5

1.4

13.15

12.73

u/l

0.53

408

2481

Amyloidosis, other/unspecified

3.27

4.92

1.3

1.4

13.67

13.08

u/l

0.10

Cholelithiasis

411

2217

1.27

4.89

1.5

1.4

14.17

12.58

u/l

4.49

396

2145

Follow-up examination after treatment for conditions other than malignant neoplasms

178

827

1.44

4.84

1.6

1.3

13.70

12.52

u/l

0.98

172

805

Psoriasis

136

912

1.50

4.84

1.4

14.16

12.82

u/l

1.16

129

881

Cardiomyopathy in other diseases

9.33

4.83

1.4

1.6

16.67

11.00

u/l

—

Exclusions for E4_PCOS_CONSORTIUM

248

1142

1.36

4.81

1.3

1.4

12.56

12.51

u/l

0.03

239

1108

Statin medication

271

1138

1.34

4.81

1.5

13.14

12.31

u/l

1.06

259

1105

Diabetic maculopathy, excluding more controls

320

1.85

4.79

1.6

1.4

19.57

12.23

u/l

4.31

312

Malignant neoplasm of prostate

142

562

1.50

4.71

1.4

12.54

13.72

u/l

1.36

136

539

Artificial opening status

158

2.23

4.69

1.3

1.5

13.20

12.99

u/l

0.07

153

malignant neoplasm of male genital organs

142

574

1.49

4.65

1.4

1.5

12.61

13.68

u/l

1.18

136

551

Sleep apnoea, including avohilmo

471

2297

1.24

4.63

1.5

1.4

12.73

12.75

u/l

0.02

454

2222

Infectious mononucleosis

2.59

4.63

2.0

1.5

13.28

12.48

u/l

0.23

Infectious mononucleosis, including avohilmo

2.59

4.63

2.0

1.5

13.28

12.48

u/l

0.23

Disorders of ocular muscles, binocular movement, accommodation and refraction

195

1398

1.38

4.61

1.5

1.4

12.72

12.54

u/l

0.08

188

1356

Periodontitis

470

2419

1.24

4.61

1.4

12.81

12.85

u/l

0.04

456

2335

Conjunctivitis (acute, non atopic)

120

789

1.52

4.61

1.5

1.4

12.99

12.70

u/l

0.16

115

760

Disorders of mineral metabolism

226

2.00

4.59

1.5

1.4

18.36

12.51

u/l

2.07

218

256

1737

1.33

4.58

1.4

13.99

13.28

u/l

0.84

243

1670

Other/unspecified enthesopathies of lower limb, excluding foot

147

2.26

4.56

1.7

1.4

12.21

13.60

u/l

0.61

142

Papulosquamous disorders

183

1314

1.40

4.55

1.4

13.87

12.90

u/l

1.00

174

1273

Congenital malformations of cardiac septa

112

2.43

4.55

1.6

1.4

12.93

13.71

u/l

0.17

106

Disorders of skin appendages

203

1475

1.37

4.53

1.7

1.4

12.21

12.58

u/l

0.35

196

1430

Schizophrenia or delusion, excluding more controls

116

754

1.52

4.52

1.4

11.19

12.99

u/l

2.20

110

727

Chronic periodontitis, including avohilmo

469

2422

1.24

4.52

1.4

12.84

12.85

u/l

0.01

455

2338

Shoulder lesions

367

1735

1.27

4.40

1.4

12.60

12.89

u/l

0.37

352

1678

Superficial injury of head

118

785

1.51

4.38

1.3

1.5

14.26

12.84

u/l

1.18

109

757

145

938

1.45

4.37

1.4

13.66

13.46

u/l

0.15

139

896

Mood disorders, excluding more controls

411

1933

1.25

4.35

1.4

12.31

13.05

u/l

1.43

401

1870

Unspecified protein-energy malnutrition

5.72

4.34

1.7

1.5

11.55

13.60

u/l

0.65

Recurrent aphthous stomatitis , including avohilmo

375

1.74

4.34

1.5

12.69

12.84

u/l

0.07

361

Implicit parasitic Sepsis

9.21

4.32

1.6

1.9

16.88

11.33

u/l

—

Carcinoma in situ of skin of other and unspecified parts of face

369

1.75

4.30

1.4

13.53

13.52

u/l

0.01

347

Coxarthrosis [arthrosis of hip](FG)

279

1473

1.31

4.27

1.4

13.86

12.87

u/l

0.90

272

1424

Other dorsopathies, not elsewhere classified

454

1910

1.24

4.23

1.5

1.4

12.71

12.86

u/l

0.17

438

1852

Diabetic retinopathy

193

870

1.38

4.20

1.5

16.14

14.42

u/l

1.93

184

834

Fracture of shoulder and upper arm

178

1289

1.38

4.20

1.4

13.05

13.15

u/l

0.07

171

1242

Inflammatory bowel disease

134

925

1.45

4.18

1.5

1.4

13.06

12.63

u/l

0.28

128

895

Other disorders of urethra and urinary system

343

1890

1.26

4.11

1.5

1.4

13.68

12.64

u/l

1.11

328

1829

Implicit parasitic Sepsis, including avohilmo

8.24

4.09

1.6

1.8

16.88

11.60

u/l

—

Cyst of kidney

230

1.93

4.06

2.1

1.4

13.05

13.31

u/l

0.10

220

Sleep disorders (combined)

516

2223

1.21

4.06

1.4

12.73

12.93

u/l

0.28

497

2147

Malignant neoplasm of liver and intrahepatic bile ducts, including Hilmo

104

2.42

4.06

1.5

1.3

19.12

14.71

u/l

1.31

Lower back pain or/and sciatica

498

2553

1.21

4.03

1.4

13.00

12.81

u/l

0.23

479

2469

Aortic aneurysm

154

1077

1.41

4.03

1.5

1.4

12.81

13.01

u/l

0.16

148

1041

Visual disturbances

227

1722

1.32

4.01

1.5

1.4

12.38

12.94

u/l

0.65

219

1667

Spirochaetal infections, other/unspecified

245

1.89

4.01

1.4

1.5

11.87

13.14

u/l

0.54

235

Other disorders of ear

434

2285

1.23

4.00

1.5

1.4

13.00

12.84

u/l

0.14

415

2216

Disorders of the thyroid gland

441

2338

1.22

3.95

1.5

1.4

13.09

12.93

u/l

0.19

427

2257

Focal epilepsy

103

684

1.51

3.92

1.4

1.5

12.88

12.89

u/l

0.00

103

657

Keratitis

162

1173

1.38

3.90

1.4

12.65

13.01

u/l

0.25

153

1135

Other/unspecified dorsalgia

173

1251

1.37

3.88

1.6

1.4

12.58

12.94

u/l

0.31

165

1215

Dorsopathies

461

1913

1.22

3.87

1.5

1.4

12.39

12.86

u/l

0.76

445

1855

Septal defects

2.41

3.87

1.5

1.4

12.75

13.16

u/l

0.08

Unspecific neurodegenerative disorder

168

1566

0.73

3.85

1.3

1.4

14.42

13.57

u/l

0.87

159

1507

Hypothyreosis and Thyroxine purchase for inclusion criteria

418

2234

1.23

3.83

1.5

1.4

13.07

12.90

u/l

0.19

405

2159

Dental operations

325

1321

1.27

3.81

1.4

12.64

13.44

u/l

1.20

313

1277

Juvenile arthritis (FINNGEN)

3.08

3.81

1.5

1.3

14.20

12.95

u/l

0.25

Allergic bronchopulmonary aspergillosis (ABPA)

12.40

3.79

1.0

2.0

11.50

9.00

u/l

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

153

2.10

3.78

1.4

1.3

17.53

14.47

u/l

1.00

146

Eustachian salpingitis and obstruction

127

2.21

3.76

1.5

1.8

10.96

12.24

u/l

0.60

121

Neuromuscular dysfunction of bladder

302

1.76

3.75

1.3

1.5

11.65

12.99

u/l

0.90

289

Crohn's disease of small intestine

134

2.18

3.73

1.6

1.4

12.28

13.16

u/l

0.23

128

Small fibre neuropathy

2.53

3.73

1.5

1.4

14.19

12.77

u/l

0.30

Viral haemorrhagic fevers, not elsewhere classified/unspecified, including avohilmo

455

1.61

3.69

1.3

1.5

12.77

12.66

u/l

0.04

438

Sequelae of injuries, of poisoning and of other consequences of external causes

103

694

1.49

3.69

1.7

1.4

12.39

12.47

u/l

0.04

673

Disorders of refraction and accommodation

101

675

1.49

3.68

1.5

11.92

12.21

u/l

0.18

660

Conductive and sensorineural hearing loss

394

2137

1.23

3.61

1.4

13.38

12.95

u/l

0.40

372

2070

Inguinal hernia

305

1611

1.26

3.59

1.4

12.63

13.24

u/l

0.88

299

1552

Other and unspecified disorders of orbit

8.02

3.59

1.1

1.2

12.29

16.11

u/l

—

Other and unspecified diseases of blood and blood-forming organs

2.68

3.57

1.7

1.4

13.11

13.42

u/l

0.06

Melanocytic naevi, other sites/unspecified

198

1.93

3.57

1.6

1.4

12.34

13.24

u/l

0.38

190

Polyarthritis, unspecified

2.41

3.57

1.7

1.5

12.91

13.70

u/l

0.24

195

1266

1.33

3.54

1.4

13.85

13.33

u/l

0.56

187

1214

Focal epilepsy, strict definition

644

1.50

3.53

1.4

1.5

13.04

12.95

u/l

0.05

619

Other mosquito-borne viral fevers, including avohilmo

10.18

3.51

1.5

1.3

14.17

13.33

u/l

—

Polycystic ovarian syndrome, consortium definition

220

962

1.31

3.50

1.6

1.4

12.46

12.27

u/l

0.13

212

933

Focal epilepsy, mode (most common among epilepsy diagnosis)

600

1.50

3.42

1.4

12.98

12.89

u/l

0.04

576

Actinic keratosis

234

1659

1.29

3.42

1.4

13.86

13.36

u/l

0.51

224

1594

Skin changes due to chronic exposure to nonionizing radiation

238

1683

1.28

3.41

1.4

13.87

13.34

u/l

0.56

227

1617

Acute pancreatitis

100

683

1.47

3.39

1.4

12.90

12.60

u/l

0.17

659

Depression

394

2168

1.22

3.38

1.4

12.20

12.78

u/l

1.00

384

2093

Conotruncal defects

7.08

3.37

1.7

1.2

11.00

15.10

u/l

—

Nonsuppurative otitis media, including avohilmo

107

638

1.45

3.37

1.4

1.5

11.47

12.23

u/l

0.68

107

619

Unstable angina pectoris

206

1240

1.31

3.36

1.4

14.23

12.96

u/l

1.94

196

1188

Benign neoplasm: Descending colon

232

1.82

3.34

1.4

12.02

13.31

u/l

0.83

221

Chronic periodontitis, complicated

268

2078

1.26

3.33

1.4

12.69

12.90

u/l

0.19

260

2010

Myocardial infarction, without ST-elevation

247

1755

1.27

3.33

1.4

14.48

13.36

u/l

1.77

239

1686

Other specified and unspecified disorders of eye and adnexa

2.43

3.31

1.5

1.4

10.25

13.34

u/l

1.67

Etanercept

115

2.18

3.28

1.4

14.60

13.38

u/l

0.23

109

Congenital malformations of spine and bony thorax, including avohilmo

8.74

3.28

1.7

1.1

10.00

16.86

u/l

—

Nonsuppurative otitis media

426

1.55

3.28

1.4

1.5

11.09

12.70

u/l

1.76

413

Hypothyroidism, other/unspecified

397

2157

1.21

3.27

1.5

1.4

13.09

12.95

u/l

0.14

384

2084

Corneal ulcer

502

1.54

3.27

1.4

1.5

12.14

12.76

u/l

0.40

486

Migraine without aura and triptan purchases

248

1.78

3.26

2.2

1.4

11.57

11.59

u/l

0.01

241

Oesophageal obstruction

116

2.18

3.23

1.4

12.84

13.51

u/l

0.27

111

Hypercalcemia

123

2.13

3.20

1.5

1.4

19.12

13.47

u/l

1.07

116

Alzheimer disease, including avohilmo

153

1417

0.75

3.20

1.3

1.4

14.08

13.58

u/l

0.46

144

1358

Postmenopausal osteoporosis with pathological fracture

150

2.01

3.20

1.8

1.4

12.20

13.52

u/l

0.51

142

Coxarthrosis

253

1289

1.27

3.19

1.4

13.82

12.77

u/l

0.88

246

1246

DVT of lower extremities

684

1.45

3.19

1.4

13.46

13.24

u/l

0.08

655

Other disorders of veins

180

1350

1.31

3.17

1.4

13.91

12.58

u/l

1.34

175

1306

Malignant neoplasm of endocrine gland, including Hilmo

124

2.10

3.13

1.4

1.3

10.58

13.88

u/l

3.03

117

Migraine with aura

483

1.53

3.13

1.5

1.4

9.93

12.57

u/l

4.89

473

Use of memantine

109

1229

0.71

3.12

1.3

1.4

15.10

13.61

u/l

1.41

104

1173

Use of other anti-dementia drugs

109

1229

0.71

3.12

1.3

1.4

15.10

13.61

u/l

1.41

104

1173

Ulcerative colitis, NAS

335

1.65

3.11

1.5

1.6

13.04

12.88

u/l

0.06

324

Depression or dysthymia

303

1335

1.24

3.09

1.5

12.72

12.90

u/l

0.18

294

1292

Sensorineural hearing loss

378

2087

1.21

3.09

1.4

13.50

12.98

u/l

0.50

356

2021

Benign neoplasm: Colon, unspecified

139

1025

1.36

3.09

1.6

1.4

13.52

13.07

u/l

0.34

132

985

Listeriosis

5.18

3.08

1.1

1.3

17.25

12.94

u/l

—

Listeriosis, including avohilmo

5.17

3.08

1.1

1.3

17.25

12.94

u/l

—

Progressive systemic sclerosis

7.72

3.08

1.8

1.1

17.83

12.75

u/l

—

Meningitis, viral

7.71

3.08

1.3

12.83

17.00

u/l

—

Respiratory conditions due to other external agents

2.71

3.07

1.3

1.4

12.60

14.10

u/l

0.33

Poisoning by narcotics and psychodysleptics [hallucinogens]

5.05

3.06

1.3

2.1

18.00

13.94

u/l

—

Maze procedure for atrial fibrillation

6.04

3.05

1.0

1.7

14.00

15.17

u/l

—

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, including Hilmo

10.38

3.00

1.0

1.2

13.20

20.40

u/l

—

Other and unspecified disorders of adult personality and behaviour

10.18

2.99

1.6

1.2

8.00

15.20

u/l

—

Other enthesopathies

123

894

1.38

2.99

1.6

1.4

13.23

12.47

u/l

0.57

115

867

Nail disorders

197

1.84

2.97

1.4

12.92

13.22

u/l

0.08

189

Retinal vascular disorders

466

1.53

2.97

1.4

12.70

13.06

u/l

0.21

446

Disorders of eyelid in diseases classified elsewhere

2.56

2.96

1.4

1.5

10.44

14.74

u/l

1.88

Fracture of foot, except ankle

655

1.44

2.92

1.9

1.4

12.64

12.32

u/l

0.15

639

Unspecified urinary incontinence

235

1.75

2.92

1.6

1.5

14.51

13.90

u/l

0.19

224

Hyperplasia of prostate

218

962

1.28

2.91

1.5

1.4

12.87

13.25

u/l

0.34

206

930

Other diseases of spinal cord

2.39

2.90

2.8

1.4

10.61

14.10

u/l

1.81

Sequelae of other external causes

142

1.98

2.90

2.3

1.4

15.04

13.52

u/l

0.44

134

Caries of dentine, including avohilmo

377

1601

1.20

2.89

1.5

1.4

12.69

13.14

u/l

0.64

365

1547

Injuries to the shoulder and upper arm

395

2560

1.19

2.86

1.5

1.4

12.87

12.93

u/l

0.06

383

2471

Diseases of the ear and mastoid process

498

2128

1.17

2.83

1.5

1.4

12.85

12.68

u/l

0.15

476

2063

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

116

2.08

2.83

1.3

16.92

14.68

u/l

0.68

109

Unspecified chronic bronchitis

103

2.15

2.81

1.7

1.4

12.18

14.24

u/l

1.35

Other disorders of central nervous system

4.50

2.80

1.5

1.6

8.63

13.78

u/l

—

Simple and mucopurulent chronic bronchitis

137

1.98

2.80

2.3

1.4

13.70

14.22

u/l

0.14

130

Other diseases of anus and rectum

149

1125

1.32

2.79

1.6

1.4

13.05

12.92

u/l

0.06

139

1090

Severe combined immunodeficiency [SCID] with reticular dysgenesis

8.65

2.77

2.4

1.5

16.60

14.83

u/l

—

Alzheimer’s disease, strict definition

100

1120

0.72

2.75

1.3

1.4

13.93

13.76

u/l

0.10

1070

Thiamine deficiency

5.13

2.75

1.4

1.8

13.71

14.43

u/l

—

Alzheimer’s disease (Late onset)

1073

0.71

2.73

1.3

1.4

13.94

13.84

u/l

0.06

1023

Schizophrenia or delusion

116

850

1.37

2.72

1.4

1.5

11.19

12.67

u/l

1.69

110

822

Disorders of adrenal gland, other and/or unspecified

6.15

2.71

1.5

1.3

9.83

15.10

u/l

—

Mood disorders

430

2333

1.18

2.71

1.4

12.29

12.84

u/l

0.99

419

2252

Polyarthrosis

620

1.41

2.71

1.4

13.00

12.52

u/l

0.28

598

Benign neoplasm: Skin of lower limb, including hip

2.52

2.71

1.7

1.4

12.73

14.00

u/l

0.28

Diabetic neuropathy

434

1.52

2.70

1.4

1.5

17.46

14.32

u/l

1.86

419

Diseases of male genital organs

262

1065

1.24

2.69

1.5

1.4

12.68

13.19

u/l

0.66

251

1032

Conduct disorder

4.24

2.68

1.0

1.6

9.50

12.79

u/l

—

Chromosomal abnormalities, not elsewhere classified

4.23

2.67

1.9

1.3

13.88

16.89

u/l

—

Mood [affective] disorders

428

2329

1.18

2.67

1.4

12.28

12.83

u/l

0.98

417

2249

Other diseases of blood and blood-forming organs

190

1.80

2.66

1.6

1.4

13.56

13.25

u/l

0.10

181

Unspecified jaundice

140

1.94

2.65

1.1

1.4

16.00

13.57

u/l

0.85

131

Acute pancreatitis (for exclusion)

100

719

1.39

2.65

1.4

12.90

12.84

u/l

0.03

690

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

133

1.96

2.65

2.6

1.4

11.35

13.13

u/l

0.64

127

Pollen allergy

307

1.61

2.64

1.3

1.4

10.68

12.16

u/l

0.95

300

Anosmia

4.81

2.63

1.0

1.4

9.14

10.36

u/l

—

Speech disturbances, not elsewhere classified

305

1.61

2.61

1.5

12.14

13.37

u/l

0.79

288

Recurrent and persistent haematuria

4.74

2.61

2.7

1.2

12.29

13.40

u/l

—

Unspecified mental disorder

150

1150

1.31

2.60

1.3

1.5

10.49

12.66

u/l

4.55

143

1115

Other inflammation of eyelid

400

1.53

2.60

1.3

1.5

12.96

13.10

u/l

0.06

384

Sulfonylureas

208

1317

1.26

2.59

1.5

1.4

17.20

12.92

u/l

8.05

192

1269

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

3.34

2.59

1.2

1.4

14.10

14.53

u/l

—

Transient retinal artery occlusion

7.52

2.58

1.0

2.0

12.20

13.86

u/l

—

Intestinal helminthiases, other/unspecified, including avohilmo

7.43

2.57

1.2

1.1

14.40

16.14

u/l

—

Behavioural disorders

4.03

2.57

1.0

1.6

9.50

13.75

u/l

—

Carcinoma in situ of skin of scalp and neck

121

2.01

2.57

1.5

1.4

15.25

13.64

u/l

0.52

111

Ulcer of oesophagus, drug-induced

5.61

2.56

1.7

1.9

13.17

12.82

u/l

—

Malignant neoplasm of stomach, including Hilmo

142

1.91

2.55

1.4

1.3

11.85

14.36

u/l

1.93

135

Presence of other devices

136

1016

1.32

2.55

1.5

1.4

15.06

12.99

u/l

2.28

129

973

Malignant neoplasm of bladder

200

1.76

2.55

1.7

1.4

13.46

14.36

u/l

0.45

191

Other juvenile arthritis

2.87

2.54

1.6

1.2

13.33

15.49

u/l

0.33

Spinal stenosis

266

1607

1.22

2.53

1.4

13.58

13.12

u/l

0.31

251

1554

Other and unspecified injuries of head

186

1.78

2.52

1.2

1.5

12.85

13.42

u/l

0.18

180

Diabetic retinopathy, strict definition

531

1.43

2.52

1.5

18.06

14.02

u/l

4.05

511

Other diseases of biliary tract

262

1.65

2.50

1.4

1.5

14.63

13.24

u/l

0.68

251

Abnormality of white blood cells, not elsewhere classified

4.44

2.48

1.9

1.1

12.29

14.19

u/l

—

Schizophrenia, schizotypal and delusional disorders

115

856

1.35

2.48

1.4

1.5

11.12

12.68

u/l

1.83

109

828

Other hearing loss

166

1260

1.28

2.46

1.5

1.4

14.27

13.28

u/l

1.18

157

1213

Benign neoplasm: Skin of trunk

103

2.05

2.42

1.7

1.4

15.43

13.03

u/l

0.54

Malignant neoplasm of liver and intrahepatic bile ducts

2.30

2.41

1.4

1.3

17.13

14.75

u/l

0.55

Disorders of plasma-protein metabolism, not elsewhere classified

5.09

2.41

1.8

12.33

14.92

u/l

—

Other specified congenital malformation syndromes affecting multiple systems

5.03

2.40

1.2

13.17

14.17

u/l

—

Malignant neoplasm of stomach

124

1.94

2.40

1.4

1.3

12.08

14.39

u/l

1.47

118

Idiopathic urticaria

3.36

2.39

1.4

1.2

9.33

15.41

u/l

—

Alzheimer disease

139

1286

0.77

2.39

1.3

1.4

14.12

13.61

u/l

0.44

131

1228

Colitis, primary sclerosing

4.16

2.36

2.3

1.6

19.71

15.12

u/l

—

Behavioural disorders, excluding more controls

3.65

2.36

1.0

1.9

9.50

17.36

u/l

—

Myasthenia gravis

2.85

2.35

1.4

11.82

12.53

u/l

0.20

Contraceptive management

635

0.68

2.35

1.6

1.4

11.35

11.76

u/l

0.21

616

Contusion of other and unspecified parts of foot

2.15

2.34

1.7

1.3

10.17

13.13

u/l

1.90

Pneumoconiosis due to asbestos and other mineral fibres

2.07

2.33

1.5

1.4

13.05

14.00

u/l

0.36

Carcinoma in situ of skin of upper limb, including shoulder

2.06

2.33

1.4

15.50

13.20

u/l

0.78

Benign neoplasm: Conjunctiva

2.20

2.31

1.1

1.4

11.35

13.94

u/l

0.93

Malignant neoplasm of pancreas

162

1.80

2.31

1.4

1.3

12.03

14.43

u/l

1.53

154

Mental retardation, excluding more controls

2.58

2.28

1.3

1.5

10.33

14.97

u/l

1.56

Drug-induced systemic lupus erythematosus

4.70

2.28

1.0

1.6

14.50

12.08

u/l

—

Childhood allergy (age < 16)

109

1.89

2.27

1.9

1.4

11.84

11.89

u/l

0.01

109

Eating disorders

148

1.83

2.27

1.4

1.7

10.52

12.70

u/l

1.29

143

Single delivery by caesarean section

205

0.50

2.26

1.3

1.6

10.00

11.40

u/l

0.61

200

Arthrosis

310

1426

1.19

2.24

1.5

1.4

12.35

12.61

u/l

0.32

301

1381

Migraine

155

946

1.28

2.24

1.7

1.4

11.06

12.29

u/l

1.87

150

926

Other and unspecified myoneural disorders

5.71

2.23

1.8

1.2

14.20

12.56

u/l

—

Bulimia nervosa (incl. atypical)

3.12

2.22

1.6

1.3

8.11

12.17

u/l

—

Toxoplasmosis

5.66

2.22

1.2

1.3

12.60

13.89

u/l

—

Shigellosis, including avohilmo

5.63

2.22

1.0

1.8

14.00

11.67

u/l

—

Other and unspecified nonscarring hair loss

5.62

2.22

1.4

1.0

11.60

11.67

u/l

—

Abnormal findings on examination of urine, without diagnosis

128

1.89

2.21

1.7

1.4

13.04

13.62

u/l

0.17

121

Other specified and unspecified personality disorders

172

1.75

2.20

1.4

11.83

13.05

u/l

0.36

165

Pneumoconiosis due to dust containing silica

4.43

2.17

1.0

1.6

11.83

14.64

u/l

—

Benign neoplasm: Short bones of lower limb

3.73

2.16

1.4

1.2

8.43

15.63

u/l

—

Diseases of pulp and periapical tissues and dental caries

317

1372

1.19

2.15

1.4

12.95

13.29

u/l

0.34

306

1325

Other crystal arthropathies

2.32

2.15

1.4

13.64

14.27

u/l

0.15

Crystal arthropathies, rheuma endpoint

2.32

2.15

1.4

1.3

13.64

13.02

u/l

0.19

Seronegative juvenile rheumatoid arthritis

4.31

2.15

1.5

1.4

11.33

14.57

u/l

—

Pemphigoid

2.02

2.11

1.8

1.3

11.63

13.89

u/l

1.05

Torsion of ovary, ovarian pedicle and fallopian tube

3.22

2.09

1.8

1.3

9.75

12.28

u/l

—

Diseases of external ear

159

1269

1.26

2.09

1.4

13.11

13.04

u/l

0.04

152

1228

Toxoplasmosis, including avohilmo

5.09

2.08

1.2

1.3

12.60

13.00

u/l

—

Malignant neoplasm of other and unspecified parts of mouth

5.09

2.08

1.2

1.0

11.60

15.30

u/l

—

Ethmoidectomy

324

1.52

2.08

1.4

1.5

12.59

12.74

u/l

0.03

313

Agoraphobia

2.91

2.07

1.8

1.4

10.00

13.23

u/l

—

Cluster headache, strict, including avohilmo

2.08

2.07

1.6

1.4

10.29

13.66

u/l

1.54

Melanoma in situ of upper limb, including shoulder

3.56

2.07

1.4

1.5

20.29

13.95

u/l

—

Other degenerative diseases of the nervous system

138

787

1.28

2.06

1.3

1.4

12.37

13.04

u/l

0.62

133

766

Varicose veins of other sites

161

1.75

2.05

1.4

1.5

12.68

13.31

u/l

0.22

156

severe traumatic brain injury, does not include concussion

122

945

1.29

2.05

1.5

1.4

14.41

13.29

u/l

0.77

117

909

Mental and behavioural disorders due to cannabinoids

3.51

2.05

1.4

1.6

8.71

16.05

u/l

—

Other and unspecified iridocyclitis

103

1.95

2.05

1.3

1.4

11.50

12.94

u/l

0.56

Menorrhagia

105

439

1.34

2.03

1.5

1.4

12.77

12.83

u/l

0.03

424

Paralytic strabismus

215

1.64

2.03

1.3

1.5

13.43

13.49

u/l

0.02

207

Hypothyroidism, strict autoimmune, 3 medication purchases required

353

2038

1.16

2.03

1.5

1.4

13.20

12.78

u/l

0.52

345

1972

Fracture of neck

200

1.66

2.02

1.3

1.4

14.36

13.81

u/l

0.13

191

Dystonia

118

1.87

2.01

1.4

10.09

14.30

u/l

3.30

111

Benign neoplasm: salivary glands, exclude unknown (D119)

255

1.57

2.00

1.9

1.4

13.30

13.14

u/l

0.04

243

Benign neoplasm: Parotid gland

232

1.60

1.99

1.8

1.4

13.41

13.17

u/l

0.06

221

Malignant neoplasm of pancreas, including Hilmo

201

1.65

1.98

1.4

12.42

13.98

u/l

0.90

192

Acute alcohol intoxication

119

925

1.29

1.97

1.3

1.4

12.61

12.91

u/l

0.18

114

893

Dental caries, including avohilmo

349

1534

1.17

1.96

1.5

1.4

12.94

13.14

u/l

0.19

337

1481

Hypertensive encephalopathy

4.67

1.96

1.6

1.4

12.00

13.45

u/l

—

Sequelae of tuberculosis

2.21

1.95

1.4

13.00

13.51

u/l

0.16

Colitis, primary sclerosing, strict definition

4.59

1.94

2.0

1.8

16.80

13.36

u/l

—

Tic disorders

4.58

1.94

1.2

1.0

8.60

16.27

u/l

—

Melanocytic naevi of upper limb, including shoulder

2.46

1.93

1.5

1.4

15.45

13.51

u/l

0.30

Diseases of oral cavity, salivary glands and jaws

284

1238

1.18

1.92

1.4

13.17

13.29

u/l

0.10

274

1190

Focal brain injury

196

1.64

1.89

1.5

12.84

13.37

u/l

0.22

189

Sequelae of tuberculosis, including avohilmo

2.17

1.89

1.4

13.00

13.52

u/l

0.17

Conjunctivitis

280

1920

1.17

1.87

1.6

1.4

11.95

12.63

u/l

0.89

273

1857

Bullous pemphigoid

2.10

1.87

1.9

1.3

12.07

13.91

u/l

0.65

Benign neoplasm of bone and articular cartilage

189

1.65

1.87

1.5

11.52

13.22

u/l

0.88

181

Dislocation, sprain and strain of joints and ligaments of thorax

2.04

1.85

1.6

1.4

10.13

13.40

u/l

2.46

Injuries to the ankle and foot

266

1930

1.18

1.85

1.6

1.4

13.12

12.46

u/l

0.43

252

1879

Cerebral aneurysm, nonruptured

213

1.60

1.85

1.2

1.5

11.71

12.86

u/l

0.67

204

Cluster headache, wide,, including avohilmo

1.94

1.85

1.6

1.4

10.06

13.44

u/l

1.70

Anogenital herpesviral [herpes simplex] infection

1.98

1.84

1.5

13.47

12.80

u/l

0.15

FESS (DNB20)

309

1.49

1.84

1.4

1.5

12.61

12.76

u/l

0.03

298

Rotator cuff syndrome

282

1655

1.17

1.84

1.4

12.61

12.90

u/l

0.32

270

1599

Superficial injury of ankle and foot

261

1.54

1.83

2.4

1.5

14.60

13.00

u/l

0.18

253

Unspecified threat to breathing

4.21

1.83

8.0

1.2

17.60

15.50

u/l

—

Toxic effect of other and unspecified substances

4.20

1.82

1.0

1.4

13.80

16.08

u/l

—

Premenstrual syndrome

4.19

1.82

1.0

1.1

8.00

13.75

u/l

—

Benign neoplasm of eye and adnexa

310

1.49

1.82

1.2

1.5

12.26

13.15

u/l

0.60

298

Injuries to the knee and lower leg

518

2488

1.13

1.81

1.4

12.96

12.82

u/l

0.16

494

2411

Kela-code for severe mental illness

131

1045

1.26

1.78

1.3

1.4

10.21

12.71

u/l

5.53

125

1011

Gingivitis and periodontal diseases

452

2058

1.13

1.78

1.4

12.88

12.95

u/l

0.07

439

1983

Other sexually transmitted chlamydial diseases

2.17

1.77

1.1

1.8

11.31

12.83

u/l

0.33

Acute gastritis

208

1.59

1.76

1.6

1.4

15.09

13.13

u/l

0.94

198

Benign thyroid growths and nodules

129

956

1.26

1.75

1.4

11.73

13.15

u/l

2.44

123

919

Postprocedural disorders of digestive system, not elsewhere classified

1.94

1.75

1.5

1.4

12.88

13.74

u/l

0.21

Status post-ami

144

880

1.24

1.74

1.3

1.4

14.59

13.04

u/l

2.64

138

846

Fracture of lower leg, including ankle

225

1865

1.19

1.74

1.5

1.4

13.67

12.80

u/l

0.78

215

1815

Inflammatory diseases of female pelvic organs

179

1008

1.22

1.74

1.4

11.78

12.37

u/l

0.49

174

977

Cystitis

377

1960

1.14

1.74

1.4

13.50

12.67

u/l

0.91

366

1898

Caries of enamel

294

2227

0.86

1.73

1.4

12.14

12.72

u/l

0.89

288

2153

Postdysenteric arthropathy

3.88

1.72

1.8

1.2

11.20

13.31

u/l

—

Tic and related disorders

3.87

1.72

1.2

1.1

8.60

15.54

u/l

—

Degenerative diseases of the nervous system

161

1409

0.82

1.72

1.3

1.4

13.78

13.56

u/l

0.17

153

1348

Malignant neoplasm of cervix uteri

3.87

1.71

1.8

1.2

9.80

11.54

u/l

—

Personal history of certain other diseases

3.86

1.71

1.4

1.5

13.20

14.31

u/l

—

Other erythematous conditions

1.96

1.70

1.2

1.4

11.75

13.06

u/l

0.44

Pure hyperglyceridaemia

2.11

1.66

1.9

1.4

13.54

13.66

u/l

0.02

Disorders of conjunctiva

324

2186

1.15

1.65

1.6

1.4

11.90

12.72

u/l

1.41

316

2116

Other and unspecified rosacea

220

1.55

1.64

1.6

1.4

11.97

13.15

u/l

0.48

211

Open wound of forearm

285

1.48

1.64

1.5

14.67

13.30

u/l

0.56

275

Rheumatoid lung disease

3.65

1.62

2.0

1.7

11.60

12.57

u/l

—

Benign neoplasm of major salivary glands

294

1.47

1.62

1.9

1.4

13.26

13.09

u/l

0.05

280

Sciatica+with lumbago

214

1604

1.18

1.61

1.6

1.4

12.40

12.74

u/l

0.37

206

1554

Herpesviral keratitis and keratoconjunctivitis

113

1.78

1.60

1.3

1.4

15.70

13.31

u/l

0.52

108

Other diseases of pancreas

262

1.49

1.60

1.6

1.4

17.87

12.94

u/l

0.74

253

Other and unspecified mental retardation

3.56

1.60

1.6

1.8

12.40

12.79

u/l

—

Deviated nasal septum

142

1159

1.23

1.59

1.4

12.33

12.88

u/l

0.58

135

1119

Complications of labour and delivery

113

788

0.80

1.59

1.5

1.4

10.92

12.21

u/l

1.57

113

765

Spondylosis

247

1658

1.16

1.55

1.5

1.4

12.78

12.95

u/l

0.15

234

1606

Unspecified/other endometriosis

157

1.63

1.54

1.8

1.3

11.19

11.30

u/l

0.03

152

Degenerative conditions of globe

3.39

1.53

1.0

1.6

9.60

16.87

u/l

—

Retinal detachments and breaks

173

1449

1.20

1.53

1.4

12.67

13.04

u/l

0.28

166

1402

Poisoning by medicine, drug-induced

3.36

1.52

1.0

1.2

7.00

15.47

u/l

—

Primary ovarian failure

3.35

1.52

1.4

1.1

8.80

14.40

u/l

—

Infective dermatitis

332

1.42

1.51

1.4

13.23

12.83

u/l

0.17

319

Redundant prepuce, phimosis and paraphimosis

727

1.27

1.50

1.4

13.40

12.80

u/l

0.40

706

Other eating disorders

2.16

1.50

1.5

1.4

8.64

12.16

u/l

2.38

Femoral hernia, unilateral

1.96

1.49

1.2

1.4

17.93

14.32

u/l

0.33

Inguinal hernia, unilateral

1.96

1.49

1.2

1.4

17.93

14.32

u/l

0.33

Inguinal of femoral hernia, unilateral

1.96

1.49

1.2

1.4

17.93

14.32

u/l

0.33

Erythema intertrigo

2.01

1.49

1.3

1.4

12.46

13.67

u/l

0.24

Acute alcohol intoxication ICD-9

109

1.75

1.47

1.3

1.4

12.21

14.64

u/l

0.80

104

Allergic colitis

3.13

1.43

1.4

1.3

11.60

12.13

u/l

—

Leiomyoma of uterus

183

864

1.19

1.42

1.4

13.02

12.39

u/l

0.28

175

836

Selective serotonin reuptake inhibitors

432

2009

1.12

1.42

1.3

1.4

12.74

13.07

u/l

0.40

416

1948

Pain and other conditions associated with female genital organs and menstrual cycle

323

1.37

1.40

1.7

1.4

10.96

12.58

u/l

1.32

316

Cholecystectomy

313

2344

1.13

1.40

1.4

13.59

12.87

u/l

1.17

299

2270

Rubella [German measles]

1.90

1.39

1.4

11.93

12.92

u/l

0.26

Rubella [German measles], including avohilmo

1.90

1.39

1.4

11.93

12.92

u/l

0.26

Benign neoplasm: Kidney

1.78

1.39

1.6

1.4

10.12

12.87

u/l

1.47

Hyperaldosteronism

1.95

1.38

1.2

1.4

14.69

12.87

u/l

0.25

Other disorders of Eustachian tube

2.01

1.38

1.8

1.4

15.58

13.74

u/l

0.26

Other inflammation of eyelid, including avohilmo

152

1272

1.20

1.38

1.4

12.81

12.62

u/l

0.12

144

1238

Olecranon bursitis

206

1.51

1.37

1.8

1.4

13.06

12.56

u/l

0.19

198

Ptosis of eyelid

365

1.37

1.36

1.5

11.42

13.21

u/l

1.65

349

Other and unspecified acne

2.96

1.36

1.0

1.2

14.20

14.88

u/l

—

Certolizumab pegol

2.95

1.36

1.0

1.2

13.40

13.82

u/l

—

Palmar fascial fibromatosis [Dupuytren]

680

1.27

1.35

1.5

1.4

13.12

13.24

u/l

0.07

653

Presbycusis

646

1.27

1.33

1.5

1.4

15.25

13.53

u/l

1.36

622

Prurigo nodularis

1.98

1.33

1.1

1.4

10.42

13.73

u/l

1.18

Organic, including symptomatic, mental disorders

284

1756

1.14

1.33

1.4

13.71

13.25

u/l

0.47

272

1695

Hemiplegia

136

1.62

1.32

1.5

1.3

12.55

13.95

u/l

0.39

128

Gonarthrosis [arthrosis of knee](FG)

312

1585

1.13

1.32

1.5

1.4

13.43

12.70

u/l

0.62

302

1533

Other disorders of optic disc

2.52

1.30

2.0

1.4

10.83

13.54

u/l

—

Dacryoadenitis

2.81

1.29

1.4

1.5

8.40

13.83

u/l

—

Benign neoplasm of urinary organs

145

1.59

1.29

1.6

1.4

10.91

13.63

u/l

1.68

136

Multiple delivery

172

0.52

1.29

1.1

1.7

11.11

11.75

u/l

—

166

Other abnormal findings of blood chemistry

122

1.65

1.27

1.5

1.4

15.05

13.08

u/l

0.46

117

Other diseases of lip and oral mucosa

161

1367

1.18

1.27

1.5

1.4

13.42

12.82

u/l

0.39

156

1325

Other specific arthropathies, wide

2.30

1.27

1.3

1.2

10.25

13.33

u/l

—

Early complications of trauma

115

1.66

1.25

2.9

1.4

12.26

13.48

u/l

0.38

110

!Aliquae complicationes praecoces traumatis

115

1.66

1.25

2.9

1.4

12.26

13.48

u/l

0.38

110

Other neurotic disorders

115

1.66

1.25

1.3

1.4

13.00

14.03

u/l

0.28

108

Other aneurysm

195

1.49

1.24

1.4

16.24

13.36

u/l

1.27

185

Disorders of breast

137

1010

1.19

1.24

1.3

1.4

11.10

12.48

u/l

1.97

130

980

Tooth agenesis EXCLUDE clefts and syndromes

2.22

1.24

1.6

1.3

13.25

12.33

u/l

—

Other disorders starting during childhood or adolescence

2.20

1.23

1.4

1.5

9.00

14.36

u/l

—

Benign neoplasm: Tongue

1.92

1.23

1.3

1.5

11.67

13.68

u/l

0.60

Carcinoma in situ of oral cavity, oesophagus and stomach

2.67

1.22

1.8

1.5

15.60

14.16

u/l

—

Unspecified parasitic disease

2.66

1.22

1.8

1.6

12.80

13.74

u/l

—

Bruxism

2.64

1.21

1.4

1.2

11.80

13.89

u/l

—

Autism

2.64

1.21

3.2

1.6

11.00

15.63

u/l

—

Chronic mastoiditis

1.81

1.21

1.5

1.3

14.86

13.92

u/l

0.15

Impotence

213

1.46

1.20

1.3

1.4

13.55

13.00

u/l

0.19

207

Sixth [abducent] nerve palsy

101

1.69

1.20

1.2

1.4

14.12

14.39

u/l

0.06

Emotional disorders starting during childhood or adolecense, excluding more controls

2.33

1.19

1.2

1.4

9.00

15.24

u/l

—

Cervical disc disorders

154

1315

1.17

1.16

1.7

1.4

12.05

12.95

u/l

1.11

147

1273

Drug-induced polyneuropathy

2.52

1.15

1.4

1.5

8.80

12.30

u/l

—

Isolated proteinuria

1.82

1.15

1.6

1.4

12.62

14.58

u/l

0.56

Diseases of appendix

286

2283

1.12

1.11

1.5

1.4

12.43

12.73

u/l

0.35

281

2206

Other and unspecified erythematous conditions

1.79

1.11

1.2

1.4

12.15

12.26

u/l

0.03

Other diseases of hard tissues of teeth

264

1211

1.13

1.10

1.4

12.51

13.23

u/l

0.99

257

1164

Unspecified parasitic disease, including avohilmo

2.40

1.09

1.8

1.6

12.80

13.67

u/l

—

Chalazion

294

1.36

1.09

1.3

1.5

11.30

12.76

u/l

1.06

284

Haemorrhoids and perianal venous thrombosis

146

1240

1.17

1.09

1.5

1.4

15.09

12.83

u/l

1.30

138

1201

Femoral hernia

136

1.55

1.08

1.3

1.4

16.14

13.88

u/l

0.31

128

Delivery, wide proxy

502

0.80

1.08

1.3

1.4

13.17

13.07

u/l

0.04

477

Injuries to the elbow and forearm

273

2088

1.12

1.08

1.4

13.05

12.71

u/l

0.35

266

2019

Mature T/NK-cell lymphomas, hilmo

2.14

1.06

1.0

1.3

17.71

13.96

u/l

—

Speech therapy

106

887

1.20

1.04

1.9

1.4

14.06

12.86

u/l

0.74

850

Benign leiomyoma with endometriosis

349

1.32

1.03

1.3

1.5

12.54

12.68

u/l

0.06

334

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.96

1.03

1.3

1.5

9.11

13.38

u/l

—

Other diseases of peritoneum

1.64

1.03

1.6

1.4

12.75

13.12

u/l

0.10

Acute appendicitis

262

2174

1.12

1.02

1.5

1.4

12.50

12.67

u/l

0.15

257

2103

Other vitreous opacities

114

1.59

1.02

1.4

13.33

13.30

u/l

0.01

108

Other congenital malformations

146

1.51

1.02

1.5

11.45

13.36

u/l

0.67

139

Pediculosis, acariasis and other infestations

130

1.54

1.02

1.6

1.4

12.60

13.13

u/l

0.13

124

Gonarthrosis

270

1362

1.12

1.02

1.5

1.4

13.26

12.65

u/l

0.43

262

1318

Other ill-defined and unspecified causes of mortality

359

1.31

1.02

1.7

1.4

13.81

14.05

u/l

0.09

338

Wide developmental disorders, excluding more controls

2.22

1.00

3.2

1.4

11.00

14.32

u/l

—

Dementia

200

1549

0.88

0.99

1.4

13.49

13.40

u/l

0.06

189

1492

Pregnancy, childbirth and the puerperium

436

0.80

0.99

1.6

1.4

13.69

13.36

u/l

0.11

413

Vitiligo

2.19

0.98

1.6

1.5

14.00

15.17

u/l

—

Appendicitis, broad definition

281

2271

1.11

0.97

1.5

1.4

12.45

12.72

u/l

0.30

276

2194

Other intervertebral disc disorders

344

1862

1.10

0.97

1.5

1.4

12.86

u/l

0.00

331

1804

Meniscus derangement

226

1332

1.13

0.97

1.4

12.87

12.63

u/l

0.23

220

1289

Melanocytic naevi of other and unspecified parts of face

132

1.52

0.97

1.8

1.4

10.95

12.95

u/l

0.88

125

Other and unspecified injuries of thorax

1.90

0.94

1.3

1.5

18.43

15.28

u/l

—

Other and unspecified visual disturbances

277

1.34

0.93

2.1

1.5

12.22

12.99

u/l

0.29

268

Assault by sharp object

2.15

0.91

1.2

1.3

10.17

13.75

u/l

—

Hypopituitarism

167

1.44

0.91

1.3

1.4

11.79

13.61

u/l

0.79

162

Viral haemorrhagic fevers, not elsewhere classified/unspecified

201

1.40

0.91

1.2

1.5

12.29

13.07

u/l

0.33

193

Other specified/unspecified soft tissue disorders

118

1.53

0.91

1.3

1.4

14.50

13.28

u/l

0.32

111

Injury of eye and orbit

360

0.72

0.90

1.5

10.65

12.33

u/l

1.31

350

Premature rupture of membranes

232

0.70

0.88

1.3

1.4

11.87

11.64

u/l

0.05

227

Spontaneous abortion

673

0.83

0.88

1.4

11.69

12.10

u/l

0.22

653

Other peripheral vascular diseases

194

1.39

0.88

1.4

13.04

13.07

u/l

0.01

187

Benign neoplasm: Caecum

397

1.26

0.84

1.4

14.14

13.16

u/l

0.51

380

Parkinson's disease, strict definition

625

0.80

0.84

1.6

1.4

12.74

13.23

u/l

0.25

597

Other salmonella infections, including avohilmo

1.57

0.84

1.6

1.4

13.07

12.66

u/l

0.08

Varicella [chickenpox], including avohilmo

1.59

0.84

1.8

1.5

11.79

12.60

u/l

0.21

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

106

897

1.17

0.83

1.5

1.4

11.88

12.15

u/l

0.14

873

Perforation of tympanic membrane

266

1.32

0.82

1.4

1.5

15.54

13.45

u/l

0.51

254

Pedal cyclist injured in transport accident

622

0.80

0.81

2.0

1.5

12.34

12.63

u/l

0.14

604

Carcinoma in situ of skin of trunk

147

1.44

0.80

1.5

1.4

14.90

14.32

u/l

0.13

136

Dementia, including avohilmo

218

1648

0.90

0.80

1.4

13.65

13.37

u/l

0.22

209

1587

Parkinson's disease

664

0.81

0.80

1.6

1.4

12.54

13.15

u/l

0.35

635

Lactose intolerance

1.73

0.79

1.5

1.4

10.40

14.02

u/l

—

Other nutritional anaemias

1.83

0.79

1.3

1.5

11.83

12.36

u/l

—

Dental pulpitis, including avohilmo

281

1969

0.91

0.79

1.3

1.4

12.29

12.50

u/l

0.20

273

1907

Other specified and unspecified retinal disorders

106

1.52

0.79

1.4

12.19

13.18

u/l

0.24

Disorders of muscles

277

1.30

0.78

1.6

1.4

12.03

12.56

u/l

0.17

267

Other salmonella infections

1.59

0.78

1.7

1.4

13.92

12.88

u/l

0.20

Ill-defined and unknown causes of mortality

393

1.25

0.78

1.7

1.4

13.53

13.96

u/l

0.18

372

Gluteal tendinitis

0.51

0.78

1.0

1.4

12.60

13.26

u/l

—

Convergent concomitant strabismus

1.59

0.78

1.7

1.4

10.38

13.43

u/l

1.74

Postpartum haemorrhage

326

0.76

0.77

2.2

1.4

10.77

11.14

u/l

0.17

319

Pedestrian injured in transport accident

174

0.63

0.76

4.0

1.4

15.09

13.66

u/l

0.22

166

Special screening examination for neoplasms

183

1.37

0.75

1.2

1.3

12.08

12.17

u/l

0.03

177

Maternal care for known or suspected abnormality of pelvic organs

259

0.76

0.75

1.3

1.4

10.72

11.53

u/l

0.45

251

Carcinoma in situ of skin, other sites/unspecified

1.68

0.75

2.0

1.4

16.44

12.83

u/l

—

Autonomic disorders

1.67

0.74

1.6

1.4

9.44

13.56

u/l

—

Wide developmental disorders

2.08

0.74

3.2

1.6

11.00

14.71

u/l

—

Vasomotor rhinitis (mode)

184

1.36

0.73

3.2

1.4

13.20

13.33

u/l

0.04

175

Parkinson's disease, including avohilmo

689

0.83

0.73

1.6

1.4

12.88

13.08

u/l

0.09

658

Other acquired deformities of musculoskeletal system and connective tissue

100

1.50

0.73

1.4

1.5

12.80

13.51

u/l

0.19

Other extrapyramidal and movement disorders in other diseases

101

875

1.16

0.73

1.4

1.5

12.12

13.02

u/l

0.73

838

Deficiency of other B group vitamins

1.61

0.72

1.1

1.4

12.89

12.88

u/l

—

Abnormal findings on antenatal screening of mother

106

0.57

0.72

1.7

1.4

8.67

10.91

u/l

—

106

Chronic suppurative otitis media, including avohilmo

202

1.34

0.72

1.4

11.78

13.64

u/l

0.98

192

Adenocarcinoma and papillary adenocarcinoma of stomach

1.58

0.71

1.3

1.2

11.33

15.73

u/l

—

Paralytic ileus

109

1.47

0.71

1.8

1.3

14.75

13.30

u/l

0.34

102

Dermatophytosis, including avohilmo

258

2317

1.09

0.70

1.4

13.55

12.77

u/l

0.84

250

2247

Nystagmus and other irregular eye movements

1.93

0.70

2.2

1.5

12.60

13.04

u/l

—

Dermatitis due to ingested food

1.92

0.70

1.2

14.80

14.28

u/l

—

Follow-up care involving plastic surgery

1.55

0.69

1.2

1.4

11.22

11.92

u/l

—

Diabetes mellitus in pregnancy

304

0.79

0.69

1.3

1.4

12.89

10.97

u/l

0.88

299

Scabies, including avohilmo

310

1.26

0.68

1.3

1.6

12.03

12.47

u/l

0.21

302

Oral leukoplakia, including avohilmo

1.65

0.68

1.2

1.3

12.80

13.71

u/l

—

Emotional disorders and disorders of social functioning with onset specific to childhood

1.67

0.68

1.1

1.5

10.57

13.61

u/l

—

Contact with heat and hot substances

119

1.43

0.67

1.2

1.4

13.76

14.19

u/l

0.07

114

Coxarthrosis, primary

287

2200

1.08

0.66

1.4

13.72

13.11

u/l

0.48

279

2117

Superficial injury of forearm

242

1.28

0.64

1.4

1.5

12.32

13.24

u/l

0.48

233

Other puerperal infections

1.48

0.64

1.4

1.8

12.14

11.57

u/l

0.12

Effects of foreign body entering through natural orifice

774

1.15

0.63

1.4

1.5

12.57

12.72

u/l

0.08

753

Conjunctivitis (acute, non atopic), including avohilmo

410

2318

1.07

0.63

1.5

1.4

12.78

12.88

u/l

0.10

395

2238

Injuries involving multiple body regions

1.52

0.62

1.4

17.33

13.11

u/l

0.71

Injury of muscle and tendon at shoulder and upper arm level

126

1411

0.89

0.62

1.3

1.4

13.44

13.04

u/l

0.24

121

1358

Impacted cerumen

415

1.21

0.62

1.7

1.4

14.16

13.06

u/l

0.48

399

Endovascular or surgical operations to intracerebral aneurysms

147

1.36

0.61

1.3

1.5

11.00

13.70

u/l

1.81

141

Vulvovaginal ulceration/inflammation in other diseases

1.46

0.61

1.8

15.71

11.60

u/l

0.83

Combinations of oral blood glucose lowering drugs

124

1107

1.12

0.60

1.5

1.4

15.30

12.44

u/l

3.31

118

1068

Frontotemporal dementia, wide, incl. Pick's disease

0.00

0.60

0.0

1.5

—

13.35

—

Postpartum hemorraghe, all women as controls

369

0.79

0.60

2.2

1.3

10.77

11.25

u/l

0.23

361

Carcinoma in situ of other and unspecified digestive organs

148

1.36

0.59

1.4

11.40

13.59

u/l

1.03

140

Lactose intolerance, other/unspecified

1.54

0.59

1.6

1.4

11.00

14.51

u/l

—

Dislocation, sprain and strain of joints and ligaments of knee

169

1677

0.91

0.58

1.6

1.4

11.30

12.39

u/l

1.79

164

1634

Coxarthrosis, primary, with hip surgery

226

1932

1.09

0.58

1.4

13.71

13.17

u/l

0.32

220

1858

Disorders of vestibular function (Vertigo)

196

1752

1.09

0.57

1.5

1.4

12.65

13.01

u/l

0.37

188

1694

Foreign body or object entering through skin

141

1.35

0.56

1.3

1.4

11.74

13.64

u/l

0.63

135

Seborrhoeic keratosis

105

934

1.13

0.56

1.4

13.15

13.21

u/l

0.03

100

902

Other diseases of gallbladder

124

1.37

0.55

1.5

1.3

13.82

13.75

u/l

0.01

119

Other appendicitis

194

1.29

0.55

1.8

1.5

11.00

13.20

u/l

1.49

187

Use of levodopa decarboxylase inhibitor

613

0.85

0.55

1.6

1.4

12.69

13.08

u/l

0.17

588

Other congenital malformations, including avohilmo

257

1.25

0.54

1.5

1.6

12.03

12.95

u/l

0.36

249

Gingival hyperplasia

1.47

0.54

1.3

14.58

14.47

u/l

0.01

Pathological resorption of teeth

1.47

0.54

1.5

1.4

15.75

13.39

u/l

0.36

Necrosis of pulp, including avohilmo

195

1773

1.09

0.54

1.3

1.4

12.64

12.46

u/l

0.13

187

1721

Use of selegiline

159

0.69

0.54

2.0

1.4

9.64

13.68

u/l

2.27

150

Alzheimer’s disease (Early onset)

159

0.69

0.54

1.3

1.4

12.36

14.06

u/l

0.78

145

Divergent concomitant strabismus

151

1.33

0.54

1.3

1.4

9.70

13.68

u/l

3.50

145

Carpal tunnel syndrome

233

1871

1.08

0.53

1.4

13.55

12.71

u/l

1.04

225

1821

Disorder of external ear, unspecified

1.49

0.53

1.1

1.3

12.55

13.81

u/l

0.26

Other sexually transmitted chlamydial diseases, including avohilmo

108

1.39

0.53

1.1

1.6

11.00

11.91

u/l

0.22

108

Melanocytic naevi of lower limb, including hip

1.43

0.53

1.5

1.4

11.62

13.43

u/l

0.51

Impingement syndrome of shoulder

798

1.13

0.52

1.4

12.69

u/l

0.00

772

Psychotic depression

132

0.68

0.51

1.2

1.5

15.56

13.70

u/l

—

126

Varicella [chickenpox]

1.45

0.51

1.3

1.4

12.25

12.82

u/l

0.12

Internal derangement of knee

135

1213

1.10

0.51

1.5

1.4

13.25

12.54

u/l

0.42

130

1172

Striking against or struck by other objects

112

1005

1.11

0.51

1.4

1.5

12.79

12.44

u/l

0.21

107

975

Hypertrophy of breast

326

0.80

0.51

1.3

1.5

11.35

12.67

u/l

0.68

318

Carcinoma in situ of colon

1.42

0.50

1.3

1.4

12.23

13.76

u/l

0.44

Other secondary gonarthrosis

144

1.32

0.50

1.7

1.4

13.37

13.23

u/l

0.02

138

Other intracranial haemorrhages

127

1.34

0.49

1.2

1.4

15.88

13.58

u/l

0.60

118

Benign neoplasm: Skin of eyelid, including canthus

509

0.84

0.49

1.4

13.09

13.14

u/l

0.01

488

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

193

1385

1.08

0.49

1.4

11.91

12.64

u/l

0.92

188

1338

Otosclerosis

212

0.75

0.48

1.4

10.75

13.39

u/l

1.79

205

Other noninflammatory disorders of cervix uteri

110

0.64

0.48

1.0

1.4

11.57

13.97

u/l

—

105

Hordeolum and other deep inflammation of eyelid

119

1.35

0.48

2.6

1.5

13.44

13.94

u/l

0.12

113

Excessive earwax

275

2337

1.07

0.48

1.5

1.4

13.45

12.99

u/l

0.50

267

2256

Artificial joint re-operation

211

0.76

0.47

1.6

1.4

13.88

13.11

u/l

0.28

200

Other arthrosis

208

1294

1.08

0.47

1.6

1.4

14.00

12.62

u/l

0.89

203

1252

Abnormal serum enzyme levels

155

1375

1.09

0.47

1.5

1.4

12.68

13.08

u/l

0.37

148

1330

Pre-eclampsia or poor fetal growth

524

0.85

0.46

1.3

1.4

12.18

11.56

u/l

0.38

507

Other specified disorders of kidney and ureter

1.40

0.44

1.4

19.83

13.86

u/l

1.50

Certain zoonotic bacterial diseases, including avohilmo

1.45

0.44

1.0

1.4

11.50

12.89

u/l

—

Female infertility, tubal origin

1.45

0.44

1.1

1.4

10.30

11.84

u/l

—

Any dementia

196

1454

0.93

0.43

1.3

1.4

13.03

13.61

u/l

0.70

185

1397

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

361

0.83

0.43

1.7

1.4

12.60

12.54

u/l

0.02

349

Other conjunctival vascular disorders and cysts

1.43

0.42

1.8

1.4

10.50

13.84

u/l

—

Primary gonarthrosis, bilateral

213

1904

0.94

0.42

1.5

1.4

13.92

13.01

u/l

0.58

207

1834

Other articular cartilage disorders

1.38

0.41

1.9

1.4

16.38

14.49

u/l

—

Extrapyramidal and movement disorders

169

1571

1.08

0.41

1.4

11.99

13.24

u/l

1.92

162

1514

Carcinoma in situ of breast, lobular

0.00

0.41

0.0

1.1

—

11.20

—

Benign neoplasm: Eye, unspecified

0.00

0.41

0.0

1.6

—

13.63

—

False labour

264

0.85

0.41

1.1

1.4

10.58

11.33

u/l

0.39

259

Disease of hard tissues of teeth, NOS

203

1137

0.93

0.41

1.6

1.4

12.50

13.07

u/l

0.59

197

1093

Ingrowing nail

105

1.34

0.41

1.4

1.3

15.21

13.18

u/l

0.30

Disorders of tooth development and eruption

338

1.16

0.41

1.5

1.4

11.62

12.67

u/l

0.47

329

Senile degeneration of the brain, not elsewhere classified

0.00

0.41

0.0

1.6

—

15.47

—

Alzheimer’s disease (Early onset), excluding more controls

141

0.73

0.40

1.3

1.6

12.36

14.57

u/l

1.07

136

Frontotemporal dementia

0.00

0.40

0.0

1.4

—

13.67

—

Chronic suppurative otitis media

177

1.24

0.40

1.5

1.4

12.18

13.71

u/l

0.60

167

Spontaneous rupture of synovium and tendon

232

1.21

0.39

1.3

1.4

12.68

12.60

u/l

0.02

223

Dementia due to Parkinson's disease

104

0.67

0.39

1.3

1.4

11.29

13.80

u/l

—

Excessive attrition of teeth

201

1867

1.07

0.38

1.4

12.00

12.53

u/l

0.58

195

1815

Infections of breast associated with childbirth

1.39

0.38

1.4

8.60

11.83

u/l

—

Type 1 diabetes, strict definition, subgroup 1

1.37

0.38

1.5

1.4

18.36

11.85

u/l

2.73

Other and/or unspecified nontoxic goitre

206

1.22

0.37

1.2

1.4

12.08

12.73

u/l

0.28

196

Other and unspecified glaucoma

243

1.20

0.37

1.4

1.5

11.17

13.64

u/l

2.42

233

Dermatographic urticaria

125

1.28

0.37

1.4

1.5

10.38

12.92

u/l

0.72

119

Benign neoplasm of other and unspecified female genital organs

0.65

0.35

1.4

16.00

13.15

u/l

—

LSIL lesion of the cervix uteri

179

0.78

0.35

1.6

13.36

11.50

u/l

0.33

173

Other osteochondropathies

153

1.24

0.35

1.8

1.4

14.47

13.42

u/l

0.21

146

Fracture of forearm

195

1649

1.06

0.35

1.3

1.4

13.02

12.76

u/l

0.21

190

1592

Emotional disorders starting during childhood or adolescence

1.38

0.34

1.2

1.6

9.00

13.91

u/l

—

Gestational [pregnancy-induced] hypertension

432

1.13

0.34

1.3

1.4

11.92

11.25

u/l

0.33

418

Mouth breathing

144

1342

1.07

0.34

1.4

12.28

12.86

u/l

0.58

137

1302

Superficial injury of shoulder and upper arm

349

1.15

0.33

1.6

1.5

12.65

12.90

u/l

0.10

334

Other/unspecified disorders of vestibular function

118

1.27

0.33

1.7

1.4

14.20

13.88

u/l

0.07

112

Injury of muscle and tendon at hip and thigh level

265

1.17

0.33

1.7

1.5

12.61

12.50

u/l

0.04

258

Any dementia, excluding more controls

174

1270

0.94

0.33

1.3

1.4

12.71

13.77

u/l

1.68

164

1220

Other deformities of toe(s)

0.69

0.33

1.7

1.5

11.50

13.74

u/l

—

Dentofacial anomalies [including malocclusion]

190

1572

0.94

0.32

1.5

1.4

11.41

12.42

u/l

1.62

184

1532

Lesion of sciatic nerve

156

1.22

0.31

1.3

1.4

16.21

13.87

u/l

0.55

149

Injuries to the wrist and hand

398

2542

1.04

0.29

1.4

12.64

12.83

u/l

0.19

383

2460

Benign neoplasm: Other and unspecified parts of mouth

1.32

0.28

1.2

1.4

11.50

13.64

u/l

—

Use of ropinirole

116

0.77

0.27

1.6

1.4

12.44

13.01

u/l

—

109

Mixed hyperlipidaemia

116

0.77

0.27

1.4

14.78

13.91

u/l

—

109

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

119

0.75

0.27

1.3

1.4

15.33

13.67

u/l

—

112

Fall on same level involving ice and snow

200

2097

0.95

0.27

1.5

1.4

13.84

12.76

u/l

1.45

192

2031

Periapical abscess

164

1554

1.06

0.27

1.3

1.4

11.48

12.78

u/l

2.20

157

1509

Pedal cyclist injured in noncollision transport accidents

279

0.86

0.27

2.5

1.4

11.63

12.87

u/l

0.56

270

Retinal haemorrhage

1.21

0.26

2.1

1.4

15.63

12.90

u/l

—

Central retinal artery occlusion

1.30

0.26

1.4

11.80

14.01

u/l

—

Glucosamine medication

204

1553

1.05

0.26

1.6

1.4

13.54

13.17

u/l

0.32

196

1493

Pedestrian injured in collision with pedal cycle

0.67

0.26

7.2

1.3

16.80

13.84

u/l

—

Varicose veins

251

1817

1.04

0.25

1.5

1.4

13.95

12.90

u/l

1.36

238

1760

Benign neoplasm: Choroid

197

1.17

0.25

1.3

1.4

12.70

13.39

u/l

0.28

188

Peripheral retinal degeneration

1.25

0.25

1.4

12.44

12.85

u/l

—

Diseases of inner ear

222

2032

1.04

0.25

1.5

1.4

12.66

12.91

u/l

0.26

213

1965

Insomnia

299

2157

0.96

0.25

1.4

12.24

12.72

u/l

0.60

292

2086

Benign neoplasm: Pituitary gland, craniopharyngeal duct

124

1.21

0.24

1.2

1.4

11.40

13.63

u/l

1.37

118

Type 1 diabetes, strict definition

1.26

0.24

1.5

1.4

18.36

12.13

u/l

2.59

Excessive vomiting in pregnancy

124

1.21

0.24

3.1

1.5

9.47

12.13

u/l

1.97

119

Anti-inflammatory and antirheumatic products, non-steroids

124

589

1.06

0.22

1.4

1.5

13.68

13.75

u/l

0.04

117

567

Endometriosis ASRM stages 1,2

323

1.12

0.22

1.6

1.5

10.28

11.61

u/l

0.89

313

Endometriosis of ovary

340

1.11

0.22

1.6

1.4

11.40

12.92

u/l

0.79

330

Glaucoma

259

2120

1.04

0.22

1.3

1.4

14.01

13.15

u/l

0.91

245

2049

Lichen sclerosus et atrophicus

263

0.87

0.22

1.8

1.4

13.26

13.10

u/l

0.04

251

Other sudden death, cause unknown

0.00

0.21

0.0

2.0

—

14.50

—

Pupillary membranes and other adhesions and disruptions of iris and ciliary body

0.00

0.21

0.0

1.9

—

11.80

—

Injury of blood vessels of thorax

0.00

0.21

0.0

1.4

—

17.00

—

Lesion of medial popliteal nerve

0.00

0.21

0.0

1.8

—

11.00

—

Other disorders of carbohydrate metabolism

0.00

0.21

0.0

1.7

—

15.45

—

Mastocytosis

0.00

0.21

0.0

1.8

—

11.90

—

Chloasma

0.00

0.21

0.0

1.1

—

15.10

—

Psoas tendinitis

0.00

0.21

0.0

1.7

—

14.60

—

Follicular adenocarcinoma of thyroid gland

0.00

0.21

0.0

1.1

—

17.09

—

Endometriosis diagnosis and infertility diagnosis occurring together

163

1.17

0.21

1.1

1.6

8.05

11.98

u/l

3.22

158

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.21

0.0

1.7

—

15.64

—

Occupant of special vehicle mainly used on industrial premises injured in transport accident

0.00

0.21

0.0

1.8

—

14.17

—

Chronic myringitis

0.00

0.21

0.0

1.7

—

12.00

—

Acute inflammation of orbit

0.00

0.21

0.0

1.3

—

15.17

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

182

1.15

0.21

1.5

1.6

14.43

12.57

u/l

0.64

175

Dislocation, sprain and strain of joint and ligaments of hip

102

0.78

0.21

1.0

1.5

15.75

13.15

u/l

—

Mixed conductive and sensorineural hearing loss

421

1.09

0.21

1.4

12.28

13.11

u/l

0.49

407

Defect, injury or illness of neck

0.00

0.21

0.0

1.6

—

13.00

—

Disorders of vitreous body and globe

209

1901

1.04

0.21

1.4

13.91

12.86

u/l

1.12

202

1833

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

211

1.14

0.20

1.4

11.92

13.32

u/l

0.57

202

Myocardial infarction, with ST-elevation

780

1.06

0.20

1.4

13.65

13.30

u/l

0.26

748

Periodontal disease, other/unspecified

1.20

0.19

1.3

1.5

15.00

15.44

u/l

—

Urolithiasis

129

1352

0.95

0.19

1.6

1.4

13.89

12.86

u/l

1.21

123

1310

Lumbar disc prolapse

242

1732

1.03

0.19

1.4

12.79

12.73

u/l

0.05

232

1680

Oral lichen planus or lichen planus, and hypothyroidism or thyroxine medication

137

1.17

0.18

1.6

1.5

13.31

12.68

u/l

0.15

129

Nontoxic single thyroid nodule

175

0.86

0.18

1.3

1.5

10.27

12.41

u/l

0.94

168

Acne, including avohilmo

265

1.10

0.18

1.2

1.4

11.31

12.00

u/l

0.27

256

Personal history of malignant neoplasm

185

1.14

0.18

1.7

1.4

12.10

12.15

u/l

0.01

175

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.17

0.18

1.4

1.3

10.29

14.22

u/l

—

Sleep disorders

315

2228

0.97

0.17

1.4

12.26

12.78

u/l

0.70

308

2155

Other obstructed labour

119

1.18

0.17

1.1

1.4

12.36

12.00

u/l

0.05

114

Endometriosis of pelvic peritoneum

290

1.10

0.17

1.6

1.4

10.46

12.73

u/l

1.52

282

Spasmodic torticollis

1.15

0.17

2.0

1.4

9.71

13.12

u/l

—

Recurrent dislocation and subluxation of joint

110

1.18

0.17

1.2

1.4

14.08

13.31

u/l

0.17

105

Benign neoplasm: Anus and anal canal

1.22

0.17

1.5

1.3

12.60

13.22

u/l

—

Benign neoplasm of other and unspecified sites

1.14

0.15

1.1

1.4

11.22

12.58

u/l

—

Pre-eclampsia

369

0.92

0.15

1.3

1.4

11.85

11.55

u/l

0.14

356

Benign neoplasm: Pancreas

1.11

0.15

1.1

1.4

13.67

13.61

u/l

—

Preterm labour and delivery

482

0.93

0.15

1.2

1.4

11.20

11.68

u/l

0.20

465

Long labour

323

1.08

0.14

1.3

1.4

11.90

11.56

u/l

0.12

314

Inflammatory disease of uterus

237

1.10

0.14

1.3

1.5

11.62

11.71

u/l

0.03

229

Polyp of the female genital tract

415

1.05

0.13

1.3

1.4

12.13

12.93

u/l

0.48

400

Parkinson's disease, strict definition, excluding more controls

495

0.94

0.13

1.6

1.4

12.74

13.64

u/l

0.48

482

Behavioural syndromes associated with physiological disturbances and physical factors

344

2278

1.02

0.13

1.4

12.26

12.82

u/l

0.84

337

2204

Calculus of kidney and ureter

117

1213

0.96

0.13

1.6

1.4

14.13

12.86

u/l

1.50

112

1173

Other peripheral vertigo

277

1.08

0.12

1.3

1.5

12.60

13.11

u/l

0.21

266

Burns and corrosions of external body surface, specified by site

277

1.08

0.12

1.2

1.5

12.93

13.05

u/l

0.03

267

Artrosis, including avohilmo

343

1840

1.02

0.12

1.5

1.4

12.61

12.77

u/l

0.18

335

1776

Systemic atrophies primarily affecting the central nervous system

133

1.13

0.12

1.3

1.4

11.47

13.66

u/l

0.91

126

Ectopic pregnancy

346

1.07

0.12

1.3

1.5

12.59

11.73

u/l

0.48

333

Cholesteatoma of middle ear

168

0.89

0.11

1.3

1.4

13.47

13.80

u/l

0.05

158

Primary open-angle glaucoma

139

1377

0.97

0.11

1.3

1.4

14.83

13.32

u/l

1.05

133

1321

Raynaud syndrome

199

0.90

0.11

1.5

13.06

12.80

u/l

0.06

191

Total colectomy operation

105

1.14

0.11

1.6

1.5

10.83

13.38

u/l

0.98

Total colectomy

105

1.14

0.11

1.6

1.5

10.83

13.38

u/l

0.98

Pregnancy hypertension

696

1.04

0.10

1.3

1.4

11.78

11.90

u/l

0.07

678

Disorders of synovium and tendon

177

1537

0.98

0.10

1.5

1.4

11.56

12.65

u/l

1.92

172

1488

Maternal care related to the fetus and amniotic cavity and possible delivery problems

457

0.96

0.10

1.7

1.4

11.99

11.47

u/l

0.25

442

Retinal breaks without detachment

506

1.05

0.09

1.6

1.4

11.72

12.18

u/l

0.24

488

Burns and corrosions

359

1.06

0.09

1.3

1.5

12.82

12.66

u/l

0.05

348

Gonarthrosis,primary

379

2318

0.99

0.09

1.5

1.4

13.38

12.99

u/l

0.34

367

2235

Glaucoma suspect

140

1434

0.98

0.09

1.4

13.76

13.16

u/l

0.36

134

1380

Cervical polyps

214

1.08

0.08

1.5

1.4

11.96

13.79

u/l

0.47

209

Impacted maxillary molar

0.83

0.08

1.2

1.5

11.80

12.87

u/l

—

Infections of genitourinary tract in pregnancy

156

1.09

0.08

1.6

1.5

12.88

11.78

u/l

0.20

150

Artificial joint operation, meniscal resection

385

2430

1.01

0.08

1.5

1.4

13.21

12.97

u/l

0.20

377

2341

Other degenerative diseases of the basal ganglia

0.86

0.07

1.0

1.4

12.50

13.13

u/l

—

Benign neoplasm: Cranial nerves

0.82

0.07

1.0

1.4

16.33

13.07

u/l

—

Left hemicolectomy

1.07

0.07

1.4

15.75

13.47

u/l

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

143

0.91

0.07

1.2

1.5

14.08

12.81

u/l

0.32

138

Carcinoma in situ of cervix uteri

143

0.91

0.07

1.0

1.6

9.77

11.72

u/l

1.31

138

Other disorders of iris and ciliary body

1.04

0.07

2.0

1.4

16.75

14.15

u/l

—

Other/unspecified synovitis and tenosynovitis

284

1.06

0.07

1.6

1.4

11.10

12.52

u/l

0.89

273

Pre-eclampsia or eclampsia

408

0.96

0.07

1.3

1.4

12.18

11.71

u/l

0.24

394

Use of rasagiline

0.82

0.07

1.4

11.86

13.73

u/l

—

Other and unspecified abdominal hernia

128

1.09

0.06

1.1

1.4

11.57

13.80

u/l

0.81

120

Parkinson's disease, excluding more controls

514

0.97

0.06

1.6

1.4

12.54

13.57

u/l

0.61

500

Fenamates

355

1.04

0.06

1.8

1.5

12.88

13.40

u/l

0.19

339

Uterine polyps

403

1.03

0.06

1.3

1.4

12.13

12.86

u/l

0.44

389

Undefined dementia

482

1.03

0.06

1.4

11.90

14.36

u/l

3.45

458

Toxic effect of contact with venomous animals

1.11

0.05

1.3

1.4

11.20

13.57

u/l

—

Fracture at wrist and hand level

107

1085

0.98

0.04

1.7

1.4

15.04

12.76

u/l

1.30

102

1050

Disorders of vitreous body

197

1857

1.01

0.03

1.4

14.12

12.86

u/l

1.38

191

1792

Otitis media, unspecified

185

1.05

0.03

1.4

1.5

16.33

12.97

u/l

0.98

179

Other superficial mycoses, including avohilmo

229

0.96

0.02

1.7

1.5

10.82

13.01

u/l

1.39

221

LSIL lesion of the cervix uteri, vagina or vulva

239

0.96

0.02

1.5

12.52

11.35

u/l

0.27

232

Conductive hearing loss, unspecified

212

1.04

0.02

1.5

12.14

13.57

u/l

0.39

205

Triptan medication for migraine, single purchase ok

204

1390

0.99

0.02

1.6

1.4

12.44

12.08

u/l

0.17

199

1358

Migraine, single triptan purchase ok & required. ICD-code if available is included

204

1390

0.99

0.02

1.6

1.4

12.44

12.08

u/l

0.17

199

1358

Pedal cyclist injured in other and unspecified transport accidents

282

1.03

0.02

1.4

1.5

12.90

13.22

u/l

0.11

274

Pterygium

103

1.07

0.02

1.5

1.3

10.55

14.09

u/l

2.43

Unspecified dementia

477

1.02

0.01

1.4

1.5

11.90

14.03

u/l

2.79

455

Other noninflammatory disorders of vagina

163

1.04

0.01

1.7

1.4

12.18

13.56

u/l

0.30

158

Benign paroxysmal vertigo

103

1039

0.99

0.01

1.6

1.4

12.81

13.26

u/l

0.31

996

Retained placenta and membranes, without haemorrhage

228

1.01

0.00

1.3

1.4

10.87

11.59

u/l

0.23

218

Other disorders of penis

365

1.01

0.00

1.6

1.4

13.43

13.09

u/l

0.16

353

Other congenital malformations of skin, including avohilmo

165

0.97

0.00

1.5

13.56

13.01

u/l

0.11

158

Separation of retinal layers (serosa)

1.01

0.00

1.2

1.4

12.10

12.91

u/l

—

Injury of muscle and tendon at lower leg level

495

0.99

0.00

1.2

1.4

12.36

12.72

u/l

0.14

481

Other secondary coxarthrosis

1.04

0.00

1.3

1.4

11.70

13.14

u/l

—

Cervicocranial syndrome

267

1.01

0.00

1.8

1.4

13.26

12.82

u/l

0.12

257

Carcinoma in situ of breast, intraductal

189

1.01

0.00

1.3

1.4

11.16

12.36

u/l

0.47

180

Atrophic disorders of skin

379

1.00

0.00

1.7

1.4

11.97

12.90

u/l

0.44

363

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

177

1.02

0.00

1.4

1.5

12.50

13.27

u/l

0.23

169

Medical treatment for female infertility

292

1.02

0.00

1.2

1.5

9.43

11.43

u/l

1.49

287

Chromomycosis and phaeomycotic abscess, including avohilmo

0.00

0.0

2.0

—

14.00

—

Hypospadias with an incomplete glans penis

0.00

0.0

1.2

—

15.00

—

Bradycardia, unspecified, drug-induced

0.00

0.0

1.3

—

14.22

—

Benign lipomatous neoplasm of spermatic cord

0.00

0.0

1.5

—

14.17

—

Carcinoma in situ of oral cavity and pharynx

0.00

0.0

1.3

—

14.50

—

Hypospadias

0.00

0.0

1.4

—

16.75

—

Other infestations

0.00

0.0

1.5

—

12.17

—

Other congenital malformations of integument, including avohilmo

0.00

0.0

1.3

—

17.00

—

Carcinoma in situ, other/unspecified

0.00

0.0

2.6

—

11.00

—

Contact with hypodermic needle

0.00

0.0

1.4

—

16.40

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.0

2.2

—

13.33

—

Accidental poisoning by and exposure to other gases and vapours

0.00

0.0

2.0

—

14.43

—

Postinfectious hypothyroidism

0.00

0.0

1.0

—

14.88

—

Unspecified pneumoconiosis

0.00

0.0

1.4

—

13.14

—

Unspecified transport accident

0.00

0.0

1.3

—

15.63

—

Nonadministration of surgical and medical care

0.00

0.0

1.5

—

15.83

—

Ankylosis of teeth

0.00

-0.00

0.0

2.4

—

12.20

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

0.00

-0.00

0.0

1.0

—

9.83

—

Use of pergolide

0.00

-0.00

0.0

2.0

—

14.75

—

Qualitative platelet defects

0.00

-0.00

0.0

1.2

—

15.50

—

Use of trihexyphenidyl

0.00

-0.00

0.0

1.4

—

18.40

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

-0.00

0.0

1.4

—

18.00

—

Aortic stenosis, including avohilmo

0.00

-0.00

0.0

2.0

—

14.00

—

Esophageal diverticulum (pouch)

0.00

-0.00

0.0

1.9

—

14.67

—

Delayed milestone in childhood

0.00

-0.00

0.0

1.0

—

17.71

—

Disorders of aromatic amino-acid metabolism

0.00

-0.00

0.0

1.9

—

13.11

—

Retinoschisis and retinal cysts

1.01

-0.00

1.3

1.4

19.86

13.45

u/l

—

Other and unspecified disorders of refraction

0.00

-0.00

0.0

1.4

—

18.20

—

Other congenital malformations of male genital organs

0.00

-0.00

0.0

1.1

—

18.78

—

Polyp of middle ear

0.00

-0.00

0.0

1.4

—

15.40

—

Juvenile cataract

0.00

-0.00

0.0

1.3

—

15.25

—

Relapsing fevers

0.00

-0.00

0.0

1.4

—

16.80

—

Multiple system atrophy (rare forms of Parkinsonism)

0.00

-0.00

0.0

1.3

—

15.57

—

Unspecified organic or symptomatic mental disorder

0.00

-0.00

0.0

1.3

—

14.25

—

Familial chondrocalcinosis

0.00

-0.00

0.0

1.1

—

13.57

—

Pituitary-dependent Cushing's disease

0.00

-0.00

0.0

1.4

—

11.40

—

Isolated patent ductus arteriosus

0.00

-0.00

0.0

1.1

—

13.14

—

Polycystic ovarian syndrome

1.02

-0.00

1.4

1.2

15.60

11.57

u/l

—

Toxic effect of other noxious substances eaten as food

0.00

-0.00

0.0

1.4

—

17.00

—

Disorder of bilirubin metabolism, other/unspecified

0.00

-0.00

0.0

1.2

—

13.00

—

Meningococcal infection, including avohilmo

0.00

-0.00

0.0

1.4

—

14.29

—

Other congenital malformations of male genital organs, including avohilmo

0.00

-0.00

0.0

1.1

—

18.78

—

Traumatic amputation of ankle and foot

0.00

-0.00

0.0

1.3

—

14.17

—

Superficial injury of ankle and foot, unspecified

0.00

-0.00

0.0

1.2

—

15.33

—

Phantom limb syndrome with pain

0.00

-0.00

0.0

2.0

—

12.33

—

Fat embolism (traumatic)

0.00

-0.00

0.0

1.3

—

19.67

—

Injury of heart

0.00

-0.00

0.0

1.3

—

22.00

—

Injury of blood vessels at shoulder and upper arm level

0.00

-0.00

0.0

1.4

—

16.60

—

Neuralgic amyotrophy

0.00

-0.00

0.0

1.6

—

12.60

—

Contact urticaria

0.00

-0.00

0.0

1.9

—

14.43

—

Injury of muscle and tendon at neck level

0.00

-0.00

0.0

1.6

—

12.20

—

Small kidney of unknown cause

0.00

-0.00

0.0

1.4

—

14.14

—

Other cestode infections, including avohilmo

0.00

-0.00

0.0

1.4

—

15.38

—

Non-seminoma of testis, including Hilmo

0.00

-0.00

0.0

1.3

—

17.75

—

Other and unspecified injuries of shoulder and upper arm

1.01

-0.00

1.3

11.86

13.94

u/l

—

Frostbite involving multiple body regions and unspecified frostbite

0.00

-0.00

0.0

1.4

—

18.20

—

Other and unspecified injuries of forearm

0.00

-0.00

0.0

1.3

—

14.50

—

Injury of blood vessels at forearm level

0.00

-0.00

0.0

2.1

—

12.00

—

Other cestode infections

0.00

-0.00

0.0

1.4

—

15.38

—

Toxic encephalopathy

0.00

-0.00

0.0

1.4

—

15.00

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

0.00

-0.00

0.0

1.0

—

9.83

—

Disorder of carbohydrate metabolism, other/unspecified

0.00

-0.00

0.0

1.9

—

14.13

—

Injury of blood vessels at hip and thigh level

0.00

-0.00

0.0

1.3

—

14.33

—

Vascular dementia (mixed)

0.98

-0.00

1.1

1.4

13.63

u/l

—

Other superficial injuries of ankle and foot

0.00

-0.00

0.0

1.1

—

15.63

—

Meningococcal infection

0.00

-0.00

0.0

1.5

—

14.67

—

Open wounds involving multiple body regions

0.00

-0.00

0.0

1.3

—

13.71

—

Carcinoma in situ of larynx

0.00

-0.00

0.0

1.2

—

18.20

—

Severe bullous disorders, KELA reimbursement

0.00

-0.00

0.0

1.4

—

12.20

—

Traumatic amputation of shoulder and upper arm

0.00

-0.00

0.0

1.4

—

15.00

—

Carcinoma in situ of uteri, other/unspecified

0.00

-0.00

0.0

1.0

—

12.50

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

2.0

—

18.00

—

Toxic effect of organic solvents

0.00

-0.00

0.0

1.4

—

17.60

—

Benign neoplasm: other/unspecified salivary gland

1.01

-0.00

2.0

1.3

12.00

13.81

u/l

—

Adenocarcinoma of small intestine

0.00

-0.00

0.0

1.2

—

13.83

—

Neuroendocrine tumor and carcinoma of stomach

0.00

-0.00

0.0

1.1

—

14.43

—

Accidental poisoning by and exposure to pesticides

0.00

-0.00

0.0

1.2

—

12.83

—

Diving or jumping into water causing injury other than drowning or submersion

0.00

-0.00

0.0

1.4

—

17.00

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.6

—

14.00

—

Mucinous and mucinous cystic tumor

0.00

-0.00

0.0

1.0

—

9.80

—

Murder, homicide, or other assault by rifle, shotgun and larger firearm discharge

0.00

-0.00

0.0

1.4

—

16.40

—

Mandibular hypoplasia

0.00

-0.00

0.0

1.1

—

15.57

—

Pedestrian injured in collision with heavy transport vehicle or bus

0.00

-0.00

0.0

1.1

—

16.14

—

Pedestrian injured in collision with other nonmotor vehicle

0.00

-0.00

0.0

1.4

—

15.40

—

Familial benign pemphigus (Hailey-Hailey disease)

0.00

-0.00

0.0

2.0

—

14.00

—

Other congenital malformations of skin

1.01

-0.00

1.3

13.71

13.70

u/l

—

Bicornuate uterus

0.00

-0.00

0.0

1.0

—

10.83

—

Accessory breast

0.00

-0.00

0.0

1.2

—

11.00

—

Respiratory distress of newborn

0.00

-0.00

0.0

1.0

—

13.50

—

Alopecia universalis

0.00

-0.00

0.0

1.2

—

14.00

—

Eccrine sweat disorders

0.00

-0.00

0.0

1.3

—

13.17

—

Prolapse and hernia of ovary and fallopian tube

0.92

-0.00

1.1

1.4

15.33

15.01

u/l

—

Use of dimethyl fumarate

0.00

-0.00

0.0

1.4

—

16.00

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

0.00

-0.00

0.0

1.0

—

11.00

—

Palatinal maxillary canine

0.00

-0.00

0.0

1.0

—

10.17

—

Maxillary prognathism

0.00

-0.00

0.0

1.4

—

11.60

—

Palatinal maxillary operation

0.00

-0.00

0.0

1.0

—

10.13

—

Yaws, including avohilmo

0.00

-0.00

0.0

1.3

—

12.43

—

Brain astrocytoma, helper endpoint

0.00

-0.00

0.0

1.3

—

19.50

—

Use of bromocriptine

0.00

-0.00

0.0

1.2

—

16.00

—

Osteolysis

0.00

-0.00

0.0

1.0

—

20.20

—

Animal-rider or occupant of animal-drawn vehicle injured in transport accident

0.00

-0.00

0.0

1.0

—

14.60

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS